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Chapter 1: 
General introduction 
The world population is predicted to increase to 9 billion by 2050 and to meet the demand for food, 
production of especially commodities associated with high incomes such as meat, will have to increase 
(FAO, 2009). As feed ingredients are expensive and animals compete with humans for the same feed 
ingredients, the aim of current research worldwide is to improve the efficiency with which animals 
utilize their feeds (Parr et al., 2016). The modern meat production industry also finds itself in a society 
that is becoming more environmentally aware and also health conscious. This has led to withdrawal 
and banning of most steroid hormone-based growth agents and also a demand for healthier meat 
with more lean tissue and less fat. The industry thus requires new safe production efficiencies to 
maximise productivity to feed the growing world population (Steenekamp, 2014; Parr et al., 2016). 
Oral synthetic beta-adrenergic agonists such as ractopamine hydrochloride, zilpaterol hydrochloride 
and r-salbutamol are examples of growth agents that are considered safe to use in feedlot production 
systems (Steenekamp, 2014). The goal of beta-agonists is to increase utilization of feed that results in 
an increase of lean carcass weight (Parr et al., 2016). These beta-agonists have pharmacological and 
chemical properties similar to natural catecholamines such as dopamine, norepinephrine and 
epinephrine (Bell et al., 1998). Beta-agonists bind to beta receptors activating receptors in muscle and 
fat tissue causing a change in biochemical growth in these tissue types (Mersmann, 1998). This results 
in repartitioning effects which seems to involve a reduction in lipogenesis, an increase in lipolysis and 
a reduction in protein breakdown which favours protein synthesis (Warriss, 2010). If nutrients are 
partitioned towards muscle growth rather than fat deposition resulting in a better dressing 
percentage, profitability and carcass leanness can be improved while feed costs can be decreased 
(Brooks et al., 2009). The improved carcass leanness can also appeal to more health conscious 
consumers. 
Zilpaterol hydrochloride is one the most researched beta-agonists and has been used legally in South 
Africa and Mexico for more than ten years and since 2006 in USA feedlots (Shook et al., 2009). It was 
shown in numerous studies to improve weight gain, feed efficiency and carcass leanness when 
administered to feedlot cattle and sheep (Brooks et al., 2009; Shook et al., 2009; Lopez-Carlos et al., 
2010; Strydom et al., 2009). However, zilpaterol hydrochloride has been shown to have a negative 
impact on meat tenderness in various studies (Strydom et al., 2011; Rathmann et al., 2008). Zilpaterol 
hydrochloride and ractopamine hydrochloride have been observed to increase lameness in cattle 
when administered in high doses and also increase death losses (Whay, 2010; Longeragan et al., 2014; 
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Montgomery et al., 2009). Furthermore, zilpaterol hydrochloride can increase heat stress in sheep and 
make pigs more susceptible to stress when handled roughly (Macias-Cruz et al., 2010; James et al., 
2013). 
The beta-agonist r-salbutamol is a purified derivative of racemic (RS-) salbutamol or albetrol which is 
used for treatment of respiratory disorders in humans all over the world.  However, the few official 
papers that have been published on its use in animals were on pigs, poultry (Marchant-Forde et al., 
2008) and one on feedlot cattle (Steenekamp, 2014). The effects r-salbutamol had on finishing pigs 
were investigated from an animal welfare perspective which may be of special interest as consumers 
are more aware of animal well-being and demand products from such systems (Steenekamp, 2014). 
R-salbutamol showed little effect on behaviour of finishing pigs over a four week period (Marchant-
Forde et al., 2008) and also had a positive effect on growth and carcass composition (Marchant-Forde 
et al., 2012). However, no research has been conducted on the use of this agent in sheep under feedlot 
conditions. When the effect of zilpaterol hydrochloride was tested on sheep meat quality specifically, 
a decrease in colour parameters, a decrease in intramuscular fat, an increase in shear force, an 
increase in connective tissue and harder meat was observed (Dávila-Ramírez et al., 2013). Feedlotting 
of sheep is on the increase in amongst others, an attempt to increase productivity and meat 
production by removing lambs earlier from grazing systems and finishing them off in feedlots.  
The aim of this study was to test the effects r-salbutamol has on apparent digestibility, feed efficiency, 
growth, and carcass characteristics of feedlot sheep. As beta-agonists’ action differs with different 
types and concentration of beta-agonists, different species and different breeds within species 
(Moody et al., 2000; NRC, 1994), two sheep breeds (medium and late maturing) were supplemented 
with three different concentrations of r-salbutamol.  
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Chapter 2: 
Literature review 
2.1. Beta-adrenergic agonists 
2.1.1 Catecholamines  
Catecholamines are mostly neurotransmitters that function within the nervous system of an animal’s 
body. These catecholamines stimulate processes that make energy available for organ systems so the 
animal can react to a predator or threat. This phenomenon is called the “fight or flight syndrome”, 
named by W.B. Cannon in 1932 (Hossner, 2005).  
The three main catecholamines found in the mammalian body are the adrenal medullary hormone, 
epinephrine and two neurotransmitters of the sympathetic nervous system called norepinephrine and 
dopamine. Epinephrine is also called adrenaline while norepinephrine is called noradrenaline 
(Mersmann, 1998; Hossner, 2005). Dopamine, epinephrine and norepinephrine are all synthesised 
from tyrosine. The decarboxylation of dihydroxyphenylalanine or DOPA forms dopamine, the 
hydroxylation product of tyrosine. Norepinephrine is the hydroxylation product of dopamine. 
Epinephrine is then the methylation product of norepinephrine (Fig 2.1.1). Epinephrine thus has an 
added methyl group distinguishing it from norepinephrine which does not (Hossner, 2005). 
 
Figure 2.1.1: Biological synthesis of catecholamines (Adapted from Fiems, 1987). 
The levels in which these catecholamines (epinephrine, norepinephrine and dopamine) circulate in 
the blood vary between species but are normally low. Dopamine and norepinephrine function as 
neurotransmitters in the nervous system and only a very high level or concentration of norepinephrine 
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is needed to induce an endocrine response. When epinephrine and dopamine are present in the blood 
circulation, it is usually due to the occurrence of sympathetic activation which causes the 
catecholamines to spill over into the blood (Hossner, 2005). The concentration in which epinephrine 
circulates is lower than the concentration of norepinephrine in most species. During stress however, 
epinephrine responds to a larger extent than norepinephrine (Mersmann, 1998). When an animal 
experiences stress from either internal or external sources, the sympathetic nervous system 
stimulates the preganglionic nerve, which causes the adrenal medulla to release epinephrine 
(Muchenje et al., 2008). Alpha and beta-receptors are the main receptors that these catecholamines 
act on as they act through specific receptors on their target tissues. The proportions of these receptors 
in various tissues determine its response to adrenergic stimulation (Smith, 1998; Parr et al., 2016). 
2.1.2 Beta-adrenergic receptors 
Beta-adrenergic receptors can be found in the plasma membrane of almost any type of tissue cells 
and like with hormones the receptors can act with either beta-agonists or catecolamines. Beta-
receptors are complex molecules and can consist of a chain of more than 400 amino acids (Smith, 
1998). These beta-receptors are linked to G proteins and occur in different forms (Hossner, 2005).  
Seven relatively hydrophobic transmembrane domains anchor the receptor in the plasma membrane 
(Fig 2.1.2). Four of these amino acid loops are on the outside of the cell membrane while three of the 
portions are on the inside of the cell. The site where the ligands bind is right in the centre of the seven 
domains (Ostrowski et al., 1992).   
 
Figure 2.1.2: A beta-adrenergic receptor with its seven domains, indicating the binding site for 
norepinephrine (Adapted from Mersmann, 1998). 
Beta-adrenergic receptors are subdivided into three subtypes. The subtypes are beta₁, beta₂ and beta₃ 
receptors, each more abundant in different tissue types where they mediate different responses 
(Hossner, 2005; Smith, 1998). Receptor subtypes will be discussed more thoroughly in the category; 
Beta-receptor subtypes. 
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2.1.3 Beta-adrenergic agonists 
Beta-agonists are compounds that occupy a beta-receptor and mimic a natural, biological mediator’s 
activity (Fiems, 1987; Parr et al., 2016). The beta-agonist is generally more potent than the 
endogenous mediator or catecholamine and usually stimulates the system maximally (Stiles et al., 
1984). The action of Beta-adrenergic agonists is in relation with the catecholamines, epinephrine and 
norepinephrine. Beta-agonists are chemically synthesized and show strong similarity with epinephrine 
as shown in Figure 2.1.3 (Fiems, 1987). 
 
Figure 2.1.3 Chemical formula of epinephrine or adrenaline and some well-known beta-agonists 
(Adapted from Fiems, 1987). 
In veterinary and human science beta-agonists are used as bronchodilators. They treat asthma, 
stimulate both rate and strength of cardiac contraction, and induce uterine relaxation. Beta-agonists 
are active when orally administered and can be used in farm animal production systems. The beta-
agonist compounds used in animal production systems have advanced effects on skeletal muscle and 
adipose tissue. In the doses used however, it has reduced effects on the cardiovascular system. When 
beta-agonists are used in animal production systems, it is referred to as repartitioning agents. This is 
due to their effects on redirecting nutrients for use in skeletal muscle at the expense of adipose tissue. 
Beta-agonists are effective in varying degrees when used in several farm animal species such as cattle, 
sheep, poultry and swine (Dunshea et al., 2005; Strydom et al., 2009). 
2.1.4 Physiological mechanism of beta-adrenergic agonists  
Beta-agonists have no effect on circulating hormones in an animal’s body but rather act on the beta-
receptors in tissues affected by the treatment (Dunshea et al, 2005). 
In order for a beta-agonist to have biological activity, it needs a hydroxyl group bonded to the beta-
carbon in the R configuration, a substituted six-membered aromatic ring, nitrogen with a positive 
charge in the ethylamine side chain, and also to have specificity for the beta-receptor, a substituent 
on the aliphatic nitrogen (Carlstrὃm et al., 1973). The catecholamines epinephrine and norepinephrine 
Stellenbosch University  https://scholar.sun.ac.za
8 
 
which are natural adrenergic neurotransmitters however, have an exception of a bulky group on the 
aliphatic nitrogen (Smith, 1998).  
Beta-agonists bind to beta-adrenergic receptors at three points on the molecule: the charged aliphatic 
amine, the beta hydroxyl group and the aromatic ring or substituents of it (Wallis, 1993; Easson & 
Stedman, 1933). Wallis, (1993) also showed that specific amino acids within the beta-adrenergic 
receptor are responsible of interacting with these three binding sites. Substituents of any of these 
sites or regions may have adverse effects on receptor binding and thus agonistic activity (Ruffolo, 
1991). 
The physiological activity a beta-agonist has is dependent on its activity at the receptor and thus the 
rates of metabolism, absorption, elimination and the resulting distribution to target tissues. This 
means that the chemical characteristics influencing a beta-agonist’s receptor activity may also 
influence the absorption, metabolism, elimination and distribution of that beta-agonist. The 
pharmacokinetic properties of individual molecules thus determine the physiological mechanism of 
beta-agonists to an extent (Smith, 1998). 
2.1.5 Molecular physiology of beta adrenergic receptors in a beta-adrenergic response 
When a beta-agonist binds to the receptor the beta-agonist receptor complex activates the Gs protein. 
The Gs protein’s α-subunit, adenylyl cyclase, the enzyme that produces cyclic adenosine 
monophosphate or cAMP is one of the major intracellular signalling molecules. cAMP produces its 
effects by binding to the regulatory subunit of protein kinase A. This then releases the catalytic subunit 
that phosphorylates intracellular proteins. These proteins include enzymes that are activated when 
phosphorylated (Altarejos and Montminy, 2011). The CREB (cAMP response element binding protein) 
is phosphorylated by protein kinase A, when this happens, the CREB binds to a response element of 
cAMP in the regulatory part of the gene and then stimulates the transcription of that gene. The 
transcriptional activity of the CREB is increased by phosphorylation, providing the mechanism of beta-
agonist receptor mediated gene transcription in the mammalian cell. Some enzymes, however get 
inactivated when phosphorylated (Strosberg, 1992; Parr et al., 2016). 
Beta adrenergic responses can be ended in various ways. Beta-agonists can be removed from the 
receptor, it can be degraded (Mersmann, 1998), the receptor can be removed from the plasma 
membrane, which will decrease the amount of receptors available to facilitate the response 
(Strosberg, 1992), or the receptor can be inactivated. The last mentioned takes place when 
phosphorylation of the receptor occurs by protein kinase A or beta-adrenergic receptor kinase 
(Altarejos and Montminy, 2011). 
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Two enzymes inactivate the natural beta-agonists epinephrine and norepinephrine. The enzymes are 
catechol-o-methyl transferase and monoamine oxidase. The catechol-o-methyl transferase methylate 
the hydroxyl group with the catechol-ring, while the monoamine oxidase deaminates the ligand 
(Mersmann, 1998). Norepinephrine can also be absorbed at the synaptic clefts and myoneural 
junctions. When the concentration of norepinephrine lowers it will lead to a decreased activation of 
receptors (Dunshea et al., 2005; Smith, 1998).    
2.1.6 Beta-receptor subtypes 
The concept of α-adrenergic receptors and β-adrenergic receptors comes from the late 1940’s when 
epinephrine and norepinephrine were used to investigate physiological functions. Both α- and β-
adrenergic receptors are stimulated by epinephrine and norepinephrine, epinephrine however is 
more effective in lower concentrations for α-adrenergic receptors than norepinephrine is. The 
classification of these receptors allows better understanding of the complexities associated with 
adrenergic functions (Mersmann, 1998; Smith, 1998). 
How tissue types respond to beta-agonist stimulation is a result of the different proportions of α- and 
β-receptors relative to one another in the cells of the tissue. Alpha-adrenergic receptors involve the 
responses associated with the sympathetic nervous system and thus affect smooth muscle contraction 
as well as vasoconstriction. Beta-receptors on the other hand are more reactive with beta-agonists 
and normally aid relaxation of smooth muscle, it is also more receptive to epinephrine than 
norepinephrine (Hossner, 2005).  
In 1967 it was found by Lands et al that beta-adrenergic receptors also had subtypes. This study led to 
the sub classification of beta receptors into Beta1- and Beta2-adrenergic receptors (Minneman et al, 
1979). In the 1970’s another subtype was found and classified as the Beta3-adrenergic receptor 
subtype (Hossner, 2005).  
Beta₁-adrenergic receptors exert its effect on intestinal smooth muscle and cardiac muscle and play a 
major role in lipolysis. Beta₁-receptors are seen as the main adrenergic receptor of the neural system. 
That is why norepinephrine is more potent for Beta1-adrenergic receptors than for Beta2-receptors 
(Mersmann, 1998). These receptor subtypes are the most abundant in various tissues in the body. 
Beta₁-receptors account for 80% of beta-receptors in adipose tissue, 70% of beta-receptors in the 
heart, 65% in the lung, 60% in skeletal muscle and 50% in the liver (Hossner, 2005). 
Beta₂-receptors respond weakly to norepinephrine and thus respond mainly to epinephrine. These 
receptors are involved in vasodilation, bronchodilation, relaxation of uterine smooth muscle, 
glycogenolysis in the liver and finally, also in the beta-agonist response of skeletal muscle (Altarejos 
and Montminy, 2011).  
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Tissue response and sensitivity to beta-agonists can be variable (Dunshea et al., 2005; Strydom et al., 
2009). As tissues can have multiple receptor subtypes (Minneman et al., 1979). Tissues thus have 
different ratios of receptor types and subtypes making its response to beta-agonists very complex. 
The same beta-agonist can be expressed differently between species and a different beta-agonist can 
then again be expressed differently within a single species (Dunshea et al., 2005).  
In a single species the ratio of Beta1- to Beta2-receptors will differ between certain cell and tissue 
types, while the ratio of Beta1- to Beta2-receptors in the same cell and tissue type but in different 
species may also differ. The ratio in which receptor subtypes are present on the plasma membrane of 
a cell can be influenced by the cell’s stage of differentiation and also the hormones interacting with it 
(Mersmann, 1989).   
Different beta-receptor subtypes have different RNA transcripts, possess different size proteins and 
also different sequences of amino acids (Mersmann, 1998). In 2002, Mersmann reported that the 
receptor subtypes have different length amino acid chains. Beta₁-receptors have a chain length of 
about 460 amino acids, Beta2-receptors a chain length of about 420 amino acids and Beta3-receptor a 
chain length of about 410 amino acids. In a single species, the three beta-receptor subtypes have 50% 
homology in their amino acid sequence. With a single Beta-receptor subtype across species, a 75% or 
more homology in the amino acid sequence was found (Strosberg, 1992; Hall et al., 1993; Pietri-Rouxel 
& Strosberg, 1995). Mersmann (2002) reports that the homology in amino acid sequence within a 
species is 45-60% and the homology in amino acid sequence for the same beta-agonist across species 
is higher than 70%.  
2.1.7 Physiological effects caused by the supplementation of synthetic beta-agonists, both direct and 
indirect 
Oral synthetic beta-agonists are similar to natural catecolamines like dopamine, epinephrine and 
norepinephrine in terms of chemical composition and physiological characteristics (NRC, 1994). As for 
the differences a single beta-agonist has on an animal, both direct and indirect, reporting effects are 
complicated. Due to beta-agonists being present on plasma membranes of cells, in a wide variety of 
tissue types (Mersmann, 1995). 
Over the years, due to large interest from the biomedical community, molecules binding to beta-
receptors were synthesised by the thousands. These molecules include both agonists and antagonists 
(Mersmann, 2002). Both bind to the receptor but the antagonist does not activate the Gs protein like 
the agonist does and therefor blocks its function (Hossner, 2005; Smith, 1998). 
Beta-agonists have the potential to increase blood flow to particular parts of the body. When the 
increase in blood flow is directed to the skeletal muscle it may enhance hypertrophy. This means that 
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increased energy sources and substrates are available for protein synthesis in skeletal muscles. Blood 
flow in adipose tissue also increases. This however may carry nonesterified fatty acids away from the 
tissue to enhance the degradation of lipids in adipose tissue. These mechanisms account for the more 
direct effects of oral beta-agonists on adipocytes and muscle cells (Dunshea et al., 2005; Mersmann, 
1998). Blood flow is likely increased to a number of organs in the mammalian body due to the 
increased heart rate many beta-agonists induces. There is also an increased blood flow to the hind 
limb of cattle with chronic or acute beta agonist administration (Eisemann et al., 1988), to the hind 
limp of sheep with chronic beta-agonist administration (Beerman et al., 1987) and to the adipose 
tissue and skeletal muscle of pigs with acute administration of beta agonists (Mersmann, 1989).  
During stress responses in animals, beta-agonists can also play an important role in relaxing and 
dilating the airways by acting on the receptors of the bronchial tracheal muscle tissue. When the 
receptors are activated, more oxygen can be distributed to the brain and muscles (Mersmann, 2002). 
In human and veterinary medicine, beta-agonists like salbutamol have been well researched and are 
used as remedies for the treatment of asthma (Steenekamp, 2014). 
Another effect of these beta-agonists is the modulation of endocrine substances circulating in the 
body (Parr et al., 2016). In sheep, plasma thyroid hormones are increased by chronic administration 
of beta-agonists Beermann et al., 1987); in cattle however, plasma thyroid hormones are not 
increased (Zimmerli & Blum, 1990). When exogenous beta-agonists were acutely administered in pigs, 
the endogenous plasma catecholamines were elevated. The elevated endogenous catecholamines 
could then mediate effects in different tissues (Mersmann, 1989). In a similar experiment in cattle by 
Blum & Flueckiger (1988), plasma concentrations of epinephrine and norepinephrine were not 
modified.  
Somatotropin is believed to not aid in the increase of muscle mass and the decrease of fat mass when 
administered (Dunshea et al., 2005). This is due to 3 main reasons. The first being the fact that 
somatotropin receptors and beta-agonist receptors have no structural relationship with one another. 
Secondly, no evidence suggests that the intracellular signalling systems of the two receptors are 
related and the third is that somatotropin produces hypertrophy in many organs while beta-agonists 
produce hypertrophic effects restricted to cardiac and skeletal muscle as well as salivary glands (Reeds 
and Mersmann, 1991). Somatotropin further causes a major reduction in feed intake while beta-
agonists have little or no effect at all (Mersmann, 1998). Oral beta-agonist administration does not 
increase plasma somatotropin secretion and when administered in sheep, it actually lowers plasma 
concentrations of somatotropin (Beermann et al., 1987; Thomas et al., 1994).   
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Modified plasma concentrations of metabolites such as lactate or glucose can arise in different tissues 
due to altered rate of metabolic pathways. This happens when exogenous beta-agonists work on 
pathways controlled by beta-receptors (Mersmann, 1998).  
Little evidence exists that beta-agonists increase basic metabolic rate when chronically administered 
(Rikhardsson et al., 1991; Yen et al., 1991). Reduced feed intake observed with certain beta-agonists 
function in that specific species when prescribed conditions exists (Dunshea et al., 2005). 
2.2 Effect of beta-agonist supplementation on feed passage rate and digestibility 
The effect of beta-agonist supplementation on rumen fermentation, passage rate and nutrient 
digestibility has been scarcely studied and little literature is available. Beta-agonists binding to beta-
adrenergic receptors along the gastrointestinal tract have been found to affect motility and secretions 
within the tract. Motility is affected when adrenoreceptor stimulation by direct beta-receptor 
mediated action on smooth muscle, reduces contraction of intestines (except at sphincters). Tonic 
activity also occurs in the beta-adrenergic pathway, as contraction pressures tends to be increased by 
beta-antagonists (McIntyre and Thompson, 1992). In humans, a beta-adrenergic pathway has shown 
to control secretomotor function. In vitro, contraction of isolated smooth muscle cells and muscle 
strips that are electrically stimulated is inhibited whilst beta-antagonists on the other hand enhance 
contraction (McIntyre and Thompson, 1992). 
In a study to evaluate the effects of ractopamine on in vitro fermentation, it was found that 
ractopamine hydrochloride affected microbial populations, stimulated microorganism fermentation 
in the rumen and improved dry matter disappearance (Lopes-Carlos et al., 2010). When cimaterol was 
administered in sheep it was found that only crude fibre decreased while other digestibility 
coefficients were unaffected. Rumen fluid however contained significantly lower concentrations of 
butyric acid and higher concentrations of acetic and propionic acids compared to the control (Fiems 
et al., 1991). Sheep fed zilpaterol-hydrochloride for 30 days had greater neutral detergent fibre (NDF) 
and gross energy (GE) intake and a tendency for higher organic matter (OM), dry matter (DM), crude 
protein (CP), acid detergent fibre (ADF) and ether extract intake than sheep fed zilpaterol 
hydrochloride for 15 days when apparent digestibility was measured. However, the DM, OM, CP, and 
GE were less in lambs fed zilpaterol-hydrochloride than that of controls (Macias-Cruz et al, 2010). 
In feedlot lambs supplemented with ractopamine- and zilpaterol hydrochloride, DM, CP, ADF, and NDF 
of both treatments had no significant differences over a control (Lopes-Carlos et al., 2010). Feedlot 
steers treated with ractopamine-hydrochloride, zilpaterol-hydrochloride and clenbuterol digested the 
same amounts of DM and CP. Lambs supplemented with cimaterol also had similar nutrient 
digestibility (Kim et al., 1989; Rikhardsson et al., 1991). Romero et al. (2011) noted that rumen 
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fermentation activities such as pH, VFA, NH₃-N, and DM degradability in the rumen were unaffected 
by zilparerol-hydrochloride treatment in feedlot steers. 
2.3 The effects of beta-agonists on growth, feed efficiency and product yield 
The first person to present data indicating that use of agents such as caffeine, nicotine, and 
epinephrine could change mammalian growth, was Cunningham in 1965. These agents can function 
by directly or indirectly changing the intracellular concentration of cAMP (Cunnigham, 1965). In the 
early 1980’s data was published on the modulation of growth in animals fed a beta-agonist, 
clenbuterol. Animals had better growth performance, a better carcass yield and also a change in body 
composition (Ricks et al., 1984). Most of the above mentioned effects were observed in cattle, pigs, 
chickens and sheep with oral administration of clenbuterol (Fiems et al., 1987; Thornton et al, 1985; 
Jones et al., 1985). In the years that followed, several other beta-agonists were fed to different species 
with similar effects (Mersmann, 1998). To date, new beta-agonists are still being tested and used. 
When an animal has a stress response where catecholamines stimulate the process of energy 
mobilization for its own survival, it seems logical that the energy will then not be available for growth. 
The catecholamine derivatives such as beta-agonists however, can improve body composition and 
production efficiency of farm animals (Hossner, 2005). Beta-agonists’ potential value lies in its 
repartitioning effects. The amount of fat in the body is decreased while protein accretion is increased. 
Increased protein accretion promotes muscle development (Warris, 2010). Beta-agonists appear to 
do this by reducing lipogenesis, increasing lipolysis and also by reducing protein degradation and 
thereby favouring protein synthesis (Warris, 2010). When nutrients are partitioned to muscle 
development rather than fat deposition, the greater dressing percentage and carcass leanness can 
increase profitability and decrease feed costs (Brooks et al., 2009). 
Beta-agonists supplementation in general showed desirable effects on growth and feedlot 
performance. The effects include increased average daily gain, better feed conversion ratio or 
efficiency and better carcass yield or conformation (Moody et al, 2000). Carcass yields can be 
increased by up to 1-2% in poultry and pigs and up to 5-6% in sheep and cattle. Evidence suggests that 
this is due to both the decrease in the size of viscera and increase in carcass weight (Warris, 2010).   
The following are examples of beta-agonists that have been extensively tested with their effect on 
growth and feed efficiency. 
2.3.1 Clenbuterol 
The beta-agonist Clenbuterol induce a decrease in total body fat content and an increase in lean tissue 
content of farm animals in general (Baker et al., 1984). This is true for species such as cattle, sheep, 
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pigs, chickens and turkeys. In some cases, an increase in weight gain and feed conversion efficiency 
were also observed (Ricks et al., 1984).  
In broiler chickens, clenbuterol has shown to increase daily weight gain, final weight and feed 
conversion ratio. The carcass yield however, was shown to be only slightly higher. The gain in carcass 
protein was also markedly higher for both males and females. The effect of Clenbuterol on growth 
was more apparent in males whereas carcass composition was more apparent in females (Rehfeldt et 
al., 2007). 
Young et al (1995) found that lambs that were treated with Clenbuterol showed no increases in carcass 
weight. The weight of individual muscles such as the semimembranosus, gastrocnemius and biceps 
femoris however, were increased.  
Clenbuterol have strong receptor affinity and its adverse effects such as increased heart rate and 
depressed appetites, makes it illegal to use as repartitioning agent for farm animals in production 
systems in most countries (Spurlock et al., 1993). 
2.3.2 Cimaterol 
Cimaterol is a phenethanolamine, the same as clenbuterol (Fiems et al, 1987). It can increase protein 
gain, decrease body fat, (especially intramuscular fat), increase daily gain, increase total carcass mass 
and also enhance muscle growth (Sainz and Wolff, 1988). This increase in muscle growth has also been 
reported to increase saleable meat in livestock (Reeds et al., 1986).  
Cimaterol too has undesirable effects like clenbuterol does. It shows potential toxic effects in humans 
when meat is consumed from animals that were supplemented with cimaterol (Dikeman, 1991). 
Cimaterol, like clenbuterol is a phenethanolamine while zilpaterol hydrochloride and ractopamine 
hydrochloride is synthetic. Cimaterol residues in tissues can thus potentially be toxic (Dikeman, 2007). 
2.3.3 Ractopamine hydrochloride 
Ractopamine hydrochloride was the first beta-agonist approved as a growth stimulant in meat 
producing animals in the USA (Hossner, 2005). It was approved by the FDA for use in pig production 
systems and feedlot cattle in the USA. It is also approved for the use in pig production systems in South 
Africa (Hossner, 2005).  
Ractopamine hydrochloride can increase average daily gain, final body weight, feed conversion 
efficiency, and dressing percentage while it decreases carcass fat. Ractopamine hydrochloride has less 
safety concerns for both humans and animals than beta-agonists such as clenbuterol and cimaterol 
(Scramlin et al., 2010). It is however, not as efficient as zilpaterol hydrochloride, and steers treated 
with zilpaterol hydrochloride showed significantly better performance in the last 33 days of feeding 
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than steers fed ractopamine hydrochloride (Scramlin et al., 2010). Marchant-Forde et al, (2003) also 
reported elevated heart rates and fatigue when handling pigs treated with ractopamine 
hydrochloride. 
2.3.4 Zilpaterol hydrochloride 
Zilpaterol hydrochloride is one of the most researched beta-agonists and has undergone extensive 
research.  It was approved for feedlot use in the USA in 2006 and has been used legally in Mexico and 
South Africa for more than 10 years (Shook et al, 2009). Feeding of zilpaterol hydrochloride has many 
benefits including; increased final body weight (Montgomery et al., 2009), higher lean yield and 
carcass weights (Montgomery et al., 2009; Leheska et al., 2009), increased average daily gain (Strydom 
et al., 2009; Montgomery et al., 2009; Elam et al., 2009), increased carcass moisture and protein with 
a decrease in carcass fat (Maritz, 1996; Hilton et al., 2009), increased dressing percentage and feed 
efficiency (Strydom et al., 2009; Montgomery et al., 2009; Elam et al., 2009) and improved protein to 
bone ratio (Maritz, 1996; Leheska et al., 2009). 
Research has also shown that Zilpaterol hydrochloride can improve carcass yield and composition in 
cattle, regardless of the feeding period (Rathmann et al., 2009). Also when fed for longer periods of 
time, it will have an even better effect on carcass fat (Elam et al., 2009). 
2.3.5 r-salbutamol 
R-salbutamol is a beta-agonist and a purified derivative of racemic salbutamol or RS salbutamol (also 
known as albetrol). It is accepted as safe and has been used as treatment for respiratory disorders in 
both humans and animals for several years (Merchant-Forde et al., 2012). Not much research has been 
done on the use of r-salbutamol in ruminants however and the limited literature published in animal 
science journals are mostly of poultry and swine (Steenekamp, 2014). R-salbutamol is currently 
considered as a popular research topic and has only recently been registered for use in feedlot cattle. 
Salbutamol has two enantiomers, which are described as two chemical molecules that represents 
mirror images of each other. There are several advantages of purifying these enantiomers to a product 
only containing the R-enantiomer. The advantages include the absence of the unwanted enantiomer 
which can interfere with the positive effects of the active enantiomer and there is also a reduction in 
negative or adverse effects caused by the unwanted enantiomer (Merchant-Forde et al., 2012). The 
pure form of r-salbutamol may cause the same physiological responses with the same efficiency as 
products containing the beta agonist racemic, but with superior safety and levels of toxicity 
(Merchant-Forde et al., 2008).  
When Merchant-Forde et al. (2008) investigated the influence of r-salbutamol on the well-being of 
finishing pigs it was found that there was little effect on the physiology and behaviour of pigs 
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supplemented with the beta-agonist over a four week period. With consumers demanding products 
of animals with better animal welfare, this study could be of particular value. It was further found that 
after 24 or 48 hours of transport, pigs that were supplemented, actually had lower heart rates than 
the control group (Merchant-Forde et al., 2008).  
R-salbutamol had positive effects on growth of supplemented pigs with improved average daily gain, 
better feed conversion efficiency, better dressing percentage of up to 2-3%, 5-6 kg heavier warm 
carcass weight and a decrease in back fat thickness of up to 3-4mm over the control group (Merchant-
Forde et al., 2012). 
When r-salbutamol and zilpaterol hydrochloride were compared in feedlot bulls, no significant 
differences in growth and feed efficiency was found in either of the beta-agonist supplemented 
animals compared to the control. R-salbutamol decreased internal carcass fat when supplemented for 
40 days in feedlot bulls compared to control animals. Percentage fat in the prime cut was lower than 
bulls fed zilpaterol hydrochloride for 30 days. A tendency for r-salbutamol treated bulls to have higher 
percentages of muscle in the prime-cut compared to zilpaterol hydrochloride treated bulls was also 
observed. This suggests that r-salbutamol is an effective agent in lipid metabolism, successful in 
depleting carcass fat. Zilpaterol hydrochloride treated bulls had a significantly lower pH 24 hours post-
mortem than r-salbutamol treated bulls when treated for the same period of time. The trend observed 
was a slower rate of pH decline from 1 hour until 24 hours post-mortem for zilpaterol hydrochloride 
treated bulls compared to r-salbutamol treated bulls and the control (Steenekamp, 2014). 
2.4 The effect of beta-agonists on meat quality  
Literature suggests that beta-agonists have undesirable or negative effects on meat quality. It was 
found that when supplemented with beta-agonists meat can decrease in tenderness (Brooks et al., 
2009). Adverse effects on sensory panel scores have also been documented (Hilton et al., 2009; 
Leheska et al., 2009). 
Over the last couple of years, focus has shifted from growth and production to consumer demands 
and perception. It is therefore just as important to study the effects of beta-agonist supplementation 
on meat quality as it is to study its effect on growth and feed efficiency (Webb, 2010). The following 
are extensively studied beta-agonists with its effects on meat and carcass characteristics.  
2.4.1 Clenbuterol 
Clenbuterol has a negative impact on meat tenderness. Animals treated with clenbuterol had higher 
Warner-Bratzler shear force values when compared to control groups (Mersmann, 1998). In cattle, 
Miller et al. (1988) found a 13.5% increase in Warner-Bratzler shear force, a 22% increase was found 
by Schiavetta et al in 1990 and 113% increase was found by Luno et al in 1999. A lower subcutaneous 
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fat thickness and marbling score was found in feedlot cattle (Strydom et al., 2009). The same author 
also found higher Warner-Bratzler shear forces in beef due to a higher calpastatin activity among 
others. 
2.4.2 Cimaterol 
As with Clenbuterol, Cimaterol also has a negative effect on meat tenderness. It shows an increase in 
shear force values of 27-45% as reported by Fiems et al. (1987), 55-145% as found by Chikhou et al. 
(1993) and 136-250% as noted by Vestergaard et al. (1994). Cimaterol also reduced fat contend in 
sheep carcasses (Rikhardsson et al., 1991). 
2.4.3 Ractopamine hydrochloride 
Ractopamine hydrochloride like other beta-agonists mentioned increases toughness of meat. A 
Warner-Bratzler shear force increase of 12% has been reported when supplemented to beef steers at 
300mg/kg per day (Shroeder et al., 2003). Increased calpastatin activity has been found to contribute 
to the higher shear force in meat from feedlot cattle (Strydom et al., 2009). Ractopamine 
hydrochloride further decreased cooling loss, USDA yield grade and fat thickness when administered 
on feedlot lambs (Lopez-Carlos et al., 2010). 
2.4.4 Zilpaterol hydrochloride 
The effects of Zilpaterol hydrochloride have been extensively researched and literature also concludes 
an increase in the toughness of meat from feedlot steers fed Zilpaterol hydrochloride (Kellermeier et 
al., 2009; Strydom et al., 2011). It was found that even with feeding durations of 20 to 40 days, 
zilpaterol hydrochloride treated steers and heifers showed greater Warner-Bratzler shear force values 
compared to control groups (Brooks et al., 2009). When supplemented for 30 to 50 days, meat from 
beef steers had 20-28% higher Warner-Bratzler shear force values (Strydom et al., 2011). The increase 
in shear force values have been reported to be due to increased calpastatin activity. By electrically 
stimulating meat treated with zilpaterol hydrochloride its toughness can be decreased by triggering 
calpains during the early onset of rigor (Hope-Jones et al., 2012). Another technique used for 
decreasing toughness of zilpterol hydrochloride treated meat is aging (Brooks et al., 2009; Holmer et 
al., 2009). However, even when electrical stimulation and aging is used, meat treated with zilpaterol 
still has higher shear force values than meat from control groups. When meat was aged for 7, 14 and 
21 days Warner-Bratzler shear force values were still higher and meat was still tougher than untreated 
meat (Rathmann et al., 2009). 
Zilpaterol hydrochloride causes an increase in drip loss and a reduced redness in meat (Hope-Jones et 
al., 2012).  Zilpaterol also decreases marbling scoreand subcutaneous fat thickness, decreases quality 
grade (Hilton et al., 2009; Montgomery et al., 2009) and has a negative effect on palatability (Leheska 
et al. 2009). 
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2.4.5 R-salbutamol 
No literature suggesting an increase in toughness of meat from animals supplemented with r-
salbutamol could be found. In a study on the palatability of pork from pigs treated with r-salbutamol, 
no increase in toughness could be detected. The possible reason for this can be the apparent increase 
in the juiciness of the meat, creating a false sensation of tenderness in the mouth when eaten (Warriss 
et al., 1991). It seems that for the above mentioned reason the panel gave meat with r-salbutamol the 
same acceptability score as control meat.  
R-salbutamol further seems to decrease drip loss and show no effect on marbling score in finisher pigs 
(Dunshea et al., 2005). This is in contrast to other beta-agonists such as Zilpaterol hydrochloride and 
cimaterol which seems to increase drip loss. Conflicting results were found by Merchant-Forde et al. 
(2012) however, which suggests lower marbling and colour score in meat from finisher pigs when 
treated with r-salbutamol. 
In a study comparing zilpaterol-hydrochloride and r-salbutamol in feedlot cattle, it was found that 
Warner-Bratzler Shear Force values for samples treated with zilpaterol-hydrochloride were 
significantly higher than r-salbutamol samples. Furthermore, no difference in shear force values were 
found in samples treated with r-salbutamol and control groups without a beta-agonist. This means 
that when treated with r-salbutamol, meat is not only less tough than zilpaterol-hydrochloride meat 
but also show no increase in toughness over control groups when administered in feedlot cattle. It is 
suggested that this is due to r-salbutamol having a more prominent effect on lipolysis and a smaller 
effect on muscle metabolism (Steenekamp, 2014). 
2.5 Beta-agonists’ effect on skeletal muscle tissue 
Beta-agonists generally increase muscle mass in farm animals such as pigs, cattle and sheep. The 
increase in muscle mass is considered to be mainly due to hypertrophy as there is no increase in DNA 
content in affected skeletal muscle (Hossner, 2005). Muscle hypertrophy has been a consistent result 
in animals supplemented with beta-agonists. When cattle were treated with zilpaterol-hydrochloride, 
a drastic increase in longissimus muscle fibre diameter over the controls were observed (Kellermeier 
et al., 2009). Zilpaterol increases the mRNA abundance of myosin heavy chain IIx. This myosin isoform 
would then be responsible for the larger diameter fibres, classified then as fast glycolytic (Baxa et al., 
2009). These findings are supported by other authors suggesting that cimaterol also increase muscle 
fibre diameter (Vestergaard et al., 1994). An increase in muscle fibre diameter results in an increase 
in the toughness of meat. Meat will thus be less tender (Dunshea et al., 2005). 
There is some confusion however, due to why the increases in muscle mass by hypertrophy occur. 
Authors found differences in protein synthesis and degradation, suggesting a combination of these 
(Dunshea et al., 2005). Initial studies on lambs found that despite an increase in muscle mass no 
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significant changes in protein synthesis were observed, suggesting reduced protein degradation 
(Bohorov, 1987). In another study where clenbuterol were fed for one week, an increase in protein 
synthesis of 45% were found in the hind limb of lambs, but only an 8% increase in protein degradation. 
The net result was an increase in muscle accretion of 130% in the hind limb (McDonagh et al., 1999). 
In a study by Bergen et al. (1989), dietary ractopamine increased protein synthesis of skeletal muscle 
by 46%. With zilpaterol-hydrochloride, proteolysis was not altered in cattle when compared to 
controls. The rate of protein degradation in steers was also shown to occur at rates similar to animals 
without a beta-agonist supplemented (Kellermeier et al., 2009). 
Many differences thus occur between individuals treated with beta-agonists. Apart from a few 
exceptions, most beta-agonists however, cause an increased protein accretion due to a reduction in 
protein degradation (Hossner, 2005). 
Protein degradation in the muscle is often measured by its protease activities. A decrease in both 
lysosomal protease activity (cathepsin B) and non-lysosomal proteinase activity (calpain µ) is observed 
with treatment of beta-agonists (Hossner, 2005). In ruminants, the activity of calpastatin, the major 
skeletal muscle inhibitor of protease, is increased by a variety of beta-agonists (Koohmaraie et al., 
1990; Kretchmar et al., 1990). The increase in calpastatin reduces activity of calpain µ (Hossner, 2005). 
This also suggests that beta-agonists tend to decrease protein degradation (Dunshea et al., 2005). 
Stimulation of muscle growth in sheep has been shown to be due to beta-agonist effects on the 
calpain-calpastatin system (Pringle et al., 1993). 
These controversial results can be due to different beta-agonists used and also due to the different 
species used in various studies (Dunshea et al., 2005). However, the effects of beta-agonists on 
skeletal muscle are time dependant; it shows rapid early growth that is later attenuated. This may be 
due to the downregulation of beta-receptors in skeletal muscle tissue (Hossner, 2005). Studies on 
rodents suggest that receptor concentration is reduced by 50% after clenbuterol was administered for 
18 days. Attenuation however, can be avoided by intermittent treatment (Hossner, 2005).   
2.6 Beta-agonists’ effect on adipose tissue 
Beta-agonists have a pronounced effect on adipose tissue and fat deposition, especially in ruminants 
(National Research Council, 1994). It acts directly on adipocytes through beta-adrenergic receptors to 
affect cellular metabolism via signalling cascades. When a beta-receptor is activated by a beta-agonist, 
protein kinase A is activated by cAMP. Protein kinase A then phosphorylates hormone sensitive lipase 
which starts the process of lipolysis (Mersmann, 2002). Beta-agonists thus indirectly lead to increased 
lipolysis and decreased lipogenesis (Dunshea et al, 2005; Mersmann, 1998). The rate of fat tissue 
growth and fat storage in adipocytes then slows, especially in ruminants, resulting in a leaner carcass 
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(Dunshea et al, 2005). The extent of this process depends on the duration and dose of 
supplementation with the beta-agonist, the type of beta-agonist used and the species it is used on 
(Beerman, 1993; Mersman, 1998). 
When used in in vitro trials, beta-agonists also inhibit triacylglycerol and fatty acid synthesis and 
stimulate degradation of adipocyte triacylglycerol in tissues or cells from several species (Mersmann, 
1998). However, beta-agonists that bind to beta-receptors and cause a decrease in fat when fed may 
have small effects on fat metabolism in adipocytes in vitro when administered in the same specie 
(Mersmann, 1995). In some cases, animals have an increased rate of lipolysis and a decreased rate of 
lipogenesis in its adipose tissue after chronic beta-agonist administration (Dunshea et al., 2005). Little 
research has been done on lipid catabolic and anabolic processes in vivo, but elevation of plasma fatty 
acid concentration that is not esterified when a beta-agonist is administered suggests that the 
adipocyte lipolytic system is activated (Dunshea et al., 2005; Mersmann, 1998).  
Ractopamine in pigs caused a decrease in fat content but little to no increase in the rate of lipid 
deposition (Dunshea et al., 1993). Other sources however, found a decrease in fat deposition when 
pigs were fed ractopamine and salbutamol (Oksbjerg, et al., 1996; Mitchell et al., 1991). 
When administered in sheep and cattle, the effects of the beta-agonist’s response on adipose tissue 
seem to be less pronounced (Beermann et al., 1987; Eisemann et al., 1988). However, fat accretion 
was still reduced in sheep due to a decrease in total fat cell number when supplemented with beta-
agonists (Coleman et al., 1986). Beta-agonists in heifers also depressed lipogenesis in subcutaneous - 
but not in intramuscular adipose tissue (Miller et al., 1988; Coleman et al., 1986). In ovine adipose 
tissue, fatty acid uptake and esterification was inhibited while lipolysis was increased by clenbuterol 
(Thornton et al., 1985).  
In vitro, lipolysis in porcine adipose tissue was not stimulated by clenbuterol, blood glycerol 
concentrations and plasma free fatty acids however, were increased (Mersmann, 1987). This indicate 
that the in vivo mechanism differ between species. In pigs it has an indirect effect and in sheep, either 
a direct effect or indirect effect (Mersmann, 1998). 
Beta-agonists are more anti-lipogenic than lipolytic, or has equal anti-lipogenic and lipolytic activity 
(Duquette and Muir, 1985). In growing animals, the anti-lipogenic function is of more importance than 
the lipolytic function. This is because 50-60% of energy deposited is protein in animals during early 
growth while 85-90% of energy deposited is fat in animals near maturity. Fat is thus more predominant 
in mature animals. An inhibition of lipogenesis is thus of more importance than lipolysis for meat 
animals still approaching maturity (Fiems, 1987; Van Es, 1977). 
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2.7. Factors affecting an animal’s response to beta-agonists 
It has been reported that differences in beta-agonist response between species, breeds, and age 
within a species also occur (Mersmann, 2002; Dunshea et al., 2005). The differences in response 
between species, breed and age of animals will be discussed below. 
2.7.1 Species differences in beta-agonist response 
The effects of beta-agonists in sheep are more pronounced than in chickens, while the effects in swine 
are intermediate and the effects in cattle more or less the same as in sheep. The possible reason for 
this is that some species such as chickens are more intensely selected and therefore closer to their 
maximal biological growth rate. There is thus less potential to improve growth. Species such as sheep 
on the other hand, have not been selected for growth rate with the same intensity and the potential 
for increased growth rate is higher. There is also the fact that particular beta-agonists are more 
effective in some species than in other (Parr et al., 2016). The given beta-agonist can thus react 
differently to the target tissue beta-receptors and can then be either more or less effective. Possible 
mechanisms responsible for this include; the beta-agonist’s affinity for the receptor, binding of the 
agonist-receptor complex to the signal transduction system, and also factors that influence the 
agonist’s delivery to the receptor sites. Additionally, beta-agonists may be inactivated at target tissues 
or the species may even have a limited number of receptors on cells in target tissues, all reducing the 
response (Dunshea et al., 2005; Mersmann, 1998). Too many factors can influence a response from 
beta-agonist treatment and to compare species, experiments needs to run simultaneously in a dose x 
response manner. 
2.7.2 The influence of breed on beta-agonist response 
It was found that when clenbuterol was administered, muscle growth of laboratory rats was depended 
on the strain of rat used (Berne et al., 1985). In Ghezel lambs, subcutaneous fat was increased at the 
8th rib by a beta-agonist metaproterenol while subcutaneous fat was decreased at the 12th rib in 
Mehran lambs due to a too high dose (Zamiri et al., 1995). This indicates that a breed X treatment 
interaction exists. Buyse et al. (1991) also noted that beta-agonist action might be influenced by 
factors such as breed. Beta-agonists have proven to be effective in a wide variety of genetic 
backgrounds (Moody et al., 2000). Cimaterol and ractopamine have both proven to be equally 
effective in a variety of genetically diverse pig breeds (Mills et al., 1994; Yen et al., 1991). However, a 
significant interaction has been reported between ractopamine and genotype for lean carcass growth 
in pigs (Gu et al., 1991). A significant difference in basal lipolytic activity was found in Suffolk and 
Southdown sired lambs (Sidhu et al., 1973). Also in cattle, lower insulin levels were found in double 
muscled animals compared to conventional animals (Michaux et al., 1982). Insulin and CAMP levels as 
discussed in the mode of action section are involved in beta-agonist activity. Finally, an interaction 
Stellenbosch University  https://scholar.sun.ac.za
22 
 
between line and cimaterol treatment was observed with mice (Eisen et al., 1988). Little other 
literature either confirming or denying these findings can be found. 
2.7.3 The influence of age on beta-agonist response 
In several species there is an improved response to beta-agonist supplementation as the animal 
becomes older (Fiems, 1987). When comparing clenbuterol treated lambs with an initial starting 
weight of 40 kg and 37.5 kg respectively, the smaller lambs showed no effect while the larger lambs 
gained weight faster than controls (Baker et al., 1984). Also in two different experiments with 10 ppm 
cimaterol, lambs in the first experiment with 17 kg starting weight showed no effect on growth rate 
while lambs in the second experiment with a starting weight of 28 kg showed a significant effect on 
growth rate (Beerman et al., 1986). In a study by Hanrahan et al. (1986), cimaterol increased live 
weight gain in steers with a starting weight of 530 kg but Ricks et al. (1984) reported no response of 
clenbuterol treated steers with starting weights of 350 kg. In veal calves, clenbuterol had no effect on 
growth rate (Williams et al., 1987). In all of the above investigations carcass fat however, was reduced. 
There are several reasons or possibilities suggested as to why beta-agonists have a reduced effect in 
younger animals. Animals from different ages can have different pharmocodynamical properties. This 
means that if beta-agonist absorption and metabolism differ in young compared to old animals, the 
optimal dose will not be the same for the different age groups (Fiems, 1987). Another possibility is 
that beta-receptor number for younger animals is too low. Lai et al. (1981) found that beta-receptors 
can increase in number by 60-70% as an animal ages; 3T3-L1 preadipocytes differentiating into 
adipocytes causes this increase in receptor number (Lai et al., 1981). It is also suggested that alteration 
of the endocrine status can cause this reduced effect of beta-agonists in young animals (Fiems, 1987). 
Older animals have lower growth hormone secretion and this could lead to an increased effect of beta-
agonists (Fiems, 1987). In cattle and lambs, plasma growth hormone concentration is lower in older 
animals than it is in younger animals (Joakimsen & Blom, 1976; Johnsson et al., 1985). In a study with 
cimaterol, it was found that endogenous anabolic factors block the anabolic effect in young animals, 
since more tyrosine was converted to muscle in larger lambs and not in smaller ones (Wilson et al., 
1988). Suggestions that sex hormones are involved in the regulation of beta-receptors also exist (Stiles 
et al., 1984). If this is true beta-agonists will have a different response in animals before puberty than 
after puberty (Fiems, 1987). 
On the other hand, feeding of beta-agonists to young cattle improves performance. An increase in 
body weight of 5.5% (Plascencia et al., 1999) and an increase in average daily gain of 26% (Avendano-
Reyes et al., 2006) have been recorded with steers fed zilpaterol hydrochloride. When fed cimaterol, 
growth, composition and eating quality were the same for both bull calves and young bulls 
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(Vestergaard & Sejrsen, 1994). Chikhou et al. (1993) also found very few interactions between 
cimaterol treatment and live weight at slaughter between different slaughter weight groups. 
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Chapter 3: 
An in vivo digestibility study to determine the effect of the beta-agonist r-
salbutamol on apparent digestibility in Dohne Merino feedlot lambs 
3.1 Abstract 
An in vivo digestibility study to determine the effects of r-salbutamol on the apparent digestibility of 
a standard feedlot diet was conducted on Dohne Merino feedlot lambs. Lambs were housed 
individually in indoor pens on Welgevallen experimental farm in Stellenbosch. Two treatment groups 
were used; a control fed commercial finisher pellets and a group fed the same finisher pellets but with 
135 mg r-salbutamol added per kg feed (on an as fed basis). Lambs from the control group had an 
average starting weight of 38.34 ± 2.80 kg whilst the 135 mg/kg r-salbutamol group had an average 
weight of 37.60 ± 2.85 kg. Faeces collection bags and urine collection harnesses were secured to each 
lamb for quantitative faecal and urine collection. The trial ran for 7 days during which lambs had access 
to ad libitum feed and water; daily feed intake was measured and feed, faeces (10% of total daily 
faeces) and urine (5% of total daily urine) samples were collected daily. A proximate (organic matter, 
ash, NDF and crude protein) analysis on the feed, faecal matter and urine (nitrogen content) samples 
showed no differences between treatment groups. R-salbutamol had no significant effect on % organic 
matter disappearance, % neutral detergent fibre, % crude protein and % nitrogen retention between 
Dohne Merino feedlot lambs. The control group had an organic matter disappearance of 70.13 ± 7.51 
% compared to the 71.27 ± 4.42 % of 135mg S/kg group, a neutral detergent fibre digestibility of 15.73 
± 3.32 % compared to 15.45 ± 2.75 %, a crude fibre digestibility of 4.56 ± 1.25 compared to the 4.30 ± 
4.56 % and a nitrogen retention of 1.15 ± 0.31 g/kg BW0.75 compared to 0.94 ± 0.29 g/kg BW0.75, none 
of which show significant difference. It may thus seem that digestibility functions are unaffected by r-
salbutamol supplementation. 
3.2 Introduction 
The rumen has a symbiotic relationship with rumen microorganisms that are able to ferment and 
degrade polysaccharides in plant cell walls. This allows ruminants to utilize forages more effectively 
(Hungate, 1966). Digestion, and especially fibre digestion of ruminants is considered to be a limiting 
factor in a wide range of ruminant production systems. Much research has been done on manipulating 
rumen activities in an attempt to maximise ruminant production by increasing digestion (Titi & 
Tabbaa, 2003). An increase in digestibility is mainly due to the stimulation of the microbial populations 
in the rumen (Beauchemin et al., 2000). By increasing fibre digestibility, synthesis of microbial protein 
in the rumen can be enhanced (Hristov et al., 1998).  
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A poorly researched compound that may have these positive effects is beta agonists. Beta-agonists 
such as ractopamine hydrochloride has been shown to affect microbial populations, stimulate 
fermentation by microorganisms and increase dry matter disappearance in series of in-vitro studies 
done by Walker & Drouillard, (2010). A decrease in crude fibre but not in other digestibility coefficients 
were observed in cimaterol treated sheep. Rumen fluid also had higher levels of propionic and acetic 
acid with lower levels of butyric acid in cimaterol treated sheep when compared to control groups 
(Fiems et al., 1987). On the other hand, others reported that beta-agonists had no effect on nutrient 
digestibility (Kim et al., 1989; Li et al., 2000; Strydom et al., 2009).  
Beta-agonists are known for their effect as repartitioning agents as well as the fact that they further 
bind to beta-receptors along the gastro intestinal tract which affects the secretory functions and 
motility of the tract (McIntyre & Thompson, 1992). As beta-agonists directly influence digestion by 
stimulating microbial activity and indirectly by changing passage rate, improved performance might 
not only be due to redistribution of absorbed nutrients but also due to improved digestibility (Macias-
Cruz et al., 2010). 
However, very little research has been done on the effect beta-agonists have on ruminant digestibility, 
and limited information is available on the positive effects they may have. The aim of this study was 
therefore to determine apparent digestibility of nutrients in feedlot sheep fed the beta-agonist r-
salbutamol, specifically looking at its influence on crude protein and Neutral Detergent Fibre (NDF) 
digestibility.  
3.3 Materials and Methods  
3.3.1 Animals 
The animals chosen for the digestibility trial were castrated male Dohne Merino lambs. Twenty 6-
month old lambs with a weight range of 35 to 38 kilograms were selected from a larger flock of feedlot 
lambs. Lambs were adapted to Meadow® complete sheep finisher pellets in a feedlot environment.  
3.3.2 Experimental procedure 
On arrival animals were processed as per usual practise and received an oral dose of Embavit® (Oral 
liquid vitamin supplement, Merial, New Zealand), Embamin® (Supplementary provision of trace 
elements, Merial, New Zealand), Ivomac® (Drench for sheep, Merial, New Zealand) and Valbazen® 
(Broad sectrum dewormer, Zoetis, USA) according to the suppliers’ directions. They were further also 
inoculated against pasteurella (OBP® Pasteurella vaccine for sheep and goats, Onderstepoort, South 
Africa) and clostridium diseases (OBP® enterotoxaemia vaccine for sheep and goats, Onderstepoort, 
South Africa). 
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After complete adaptation of 7 days lambs were randomly divided and housed in group pens for three 
days to adapt to the new environment. The digestibility study was performed in two consecutive trials 
which were repetitions of one another. This was done to minimize workload and also for more 
accurate feeding and sample collection. Ten animals (per trial) were randomly selected and moved to 
individual pens. Pens were designed with fenced sides to simulate a feeling of being in a group while 
individual intake could also be measured accurately. Faecal bags and urine collection harnesses were 
secured to each sheep and the wethers were allowed five days to adapt. After the adaptation period, 
the animals were weighed and the collection period of the trial started. Treatments were allocated as 
shown in Figure 3.1. Two treatment groups were used (5 sheep per treatment per trial); Meadow® 
complete sheep finisher pellets as the control and Meadow® complete sheep finisher pellets 
containing the beta-agonist r-salbutamol in the concentration of 135 mg/kg feed on an as fed basis 
(Table 3.1). The dosage was chosen according to the manufacturer’s recommendations after a pilot 
study was done. Animals were fed three times a day, at 07:00, 13:00 and 19:00 hours. Feed was 
weighed out in the morning and refusals weighed back the following morning after 24h to determine 
daily intake. Faeces were weighed twice daily and a sample taken for analyses while urine was 
measured once every day and a sample also taken for analysis. The collection period ran for 7 days, 
where after animals were weighed and removed from the individual pens. The procedure was 
repeated for the second batch of animals as soon as the first batch was removed. Samples were frozen 
to be analysed at a later stage.  
 
Figure 3.1 Shed layout with the treatment allocation in the individual pens 
 
  
135 mg/kg Control 135 mg/kg Control
Passageway
135 mg/kg Control 135 mg/kg Control 135 mg/kg Control
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Table 3.1 Nutritional information of Meadow® complete sheep finisher pellets 
Nutrient Quantity (g/kg) Max/Min 
Protein 120 Min 
Fat 25 Min 
Fat 70 Max 
Fibre 110 Min 
Fibre 200 Max 
Moisture 120 Max 
Calcium 10 Max 
Phosphorus 2 Min 
Urea 10 Max 
 
3.3.4 Sample collection  
A 10% faecal matter sample of each sheep as well as a 5% urine sample was taken daily for proximate 
analysis. Feed samples (50 g) were also taken daily and pooled for both treatments. The analysed 
nutrients of the feed did not differ substantially as shown in Table 3.2. The fat, ash, crude protein, 
crude fibre and average gross energy on a Dry Matter (DM) basis of the two diets are summarised in 
Table 3.2. 
Table 3.2 Nutrients of the control diet containing no beta-agonist and the diet containing 135 mg r-
salbutamol per kg of feed   
Nutrients Treatment 
Control 135 mg S/kg 
Fat (%) 3.79 3.78 
Ash (%) 7.62 7.52 
Moisture (%) 9.91 10.12 
Average crude protein (%) 14.83 14.12 
Crude fibre (%) 14.95 13.87 
Average Gross energy (MJ/kg) 18.23 17.77 
NDF (%) 32.15 31.98 
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3.3.5 Sample preparation 
Feed 
The sample was mixed on a clean non-absorbent surface and sub-sampled by quartering. Quartering 
was done by dividing the flattened heap into quarters and rejecting the two diagonally opposite 
portions. The remaining material was then re-mixed and the process repeated until a 200-300g sample 
was obtained. 
Faeces 
The wet faeces were weighed accurately in a clean, dry and empty tinfoil tray. Approximately 500g of 
the sample was dried at 60°C for three days. The moisture free tray and sample were then re-weighed.  
All feed and faecal samples were ground in a hammer mill with a 1mm diameter sieve to ensure all 
samples were homogenised. 
3.3.6 Chemical analyses of samples 
Faecal and feed samples were analysed for moisture, ash, Neutral Detergent Fibre (NDF) and crude 
protein while urine was analysed for nitrogen content. The proximate analysis was done in duplicate 
on all twenty faecal samples as well as the two feed samples. Analysis for nitrogen content in urine 
was also done in duplicate.  
Moisture 
AOAC (2002) official method 934.01: For determination of moisture content 
For moisture analysis, a 2g sample was weighed accurately into a moisture free crucible. After samples 
were dried in the drying oven at 105°C for 24 hours they were placed in a desiccator to cool down. 
The moisture free crucible was then weighed accurately. % Moisture was calculated with the following 
formula: 
% 𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 =
(𝐷𝑟𝑦 𝑐𝑟𝑢𝑐𝑖𝑏𝑙𝑒 + 𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡
− (𝐷𝑟𝑦 𝑠𝑎𝑚𝑝𝑙𝑒) 𝑥 
100
1
 
                    % Dry Matter = 100 - % Moisture 
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Organic Matter Disappearance 
Organic matter disappearance was calculated for each sheep with the formulae as follows: 
% 𝑂𝑀𝐷 =  
𝐹𝑒𝑒𝑑 𝑂𝑀 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑔) − 𝐹𝑎𝑒𝑐𝑒𝑠 𝑂𝑀 𝑒𝑥𝑐𝑟𝑒𝑡𝑖𝑜𝑛(𝑔)
𝐹𝑒𝑒𝑑 𝑂𝑀 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑔)
 𝑋 
100
1
 
 
Ash 
AOAC (2002) official method 942.05: For determination of ash content 
Crucibles with the dry samples were places in an ashing furnace at 500°C for 6 hours. The samples 
were left to cool for 30 minutes before the crucible with ash was weighed accurately. The % ash was 
calculated by: 
% 𝐴𝑠ℎ =  
(𝐶𝑟𝑢𝑐𝑖𝑏𝑙𝑒 𝑤𝑖𝑡ℎ 𝑎𝑠ℎ) − (𝐶𝑙𝑒𝑎𝑛 𝑐𝑟𝑢𝑐𝑖𝑏𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡
 𝑋 
100
1
 
 
Neutral Detergent Fibre (NDF) 
Method used as described by Van Soest et al., (1991) for NDF determination 
NDF is determined gravimetrically, after chemical digestion and solubilisation of compounds such as 
protein, starch and other digestible carbohydrates with a NDF solution. An ANKOM220 Fibre Analyser 
(ANKOM Technologies, Fairport, NY, USA) was used for determining % NDF. A 1g sample was boiled 
(65°C) with a NDF solution and 0.1 ml heat stable α-Amylase in a hot extraction unit, washed, dried 
for 24 hours at 100°C and ashed at 500°C for 6 hours. Finally the sample was cooled and weighed 
accurately. Calculations for lab values of feed and faeces were done with the following formulae: 
% 𝑁𝐷𝐹
=  
(𝑀𝑎𝑠𝑠 𝑜𝑓 𝑐𝑟𝑢𝑐𝑖𝑏𝑙𝑒 𝑎𝑓𝑡𝑒𝑟 𝑑𝑟𝑦𝑖𝑛𝑔, 𝑖𝑛 𝑔) − (𝑀𝑎𝑠𝑠 𝑜𝑓 𝑐𝑟𝑢𝑐𝑖𝑏𝑙𝑒 𝑎𝑓𝑡𝑒𝑟 𝑎𝑠ℎ𝑖𝑛𝑔, 𝑖𝑛 𝑔)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑚𝑎𝑠𝑠 𝑖𝑛 𝑔
  𝑋 
100
1
 
To determine the % NDF digested, the following formulae was used: 
𝐷𝑖𝑔𝑒𝑠𝑡𝑖𝑏𝑖𝑙𝑖𝑡𝑦 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
=  
((𝐷𝑀 𝐼𝑛𝑡𝑎𝑘𝑒 𝑖𝑛 𝑔) 𝑋
(% 𝑁𝐷𝐹 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑒𝑒𝑑)
100 ) − (
(𝐷𝑀 𝐸𝑥𝑐𝑟𝑒𝑡𝑖𝑜𝑛 𝑖𝑛 𝑔 ) 𝑋
(% 𝑁𝐷𝐹 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑎𝑒𝑐𝑒𝑠)
100 )  
(𝐷𝑀 𝐼𝑛𝑡𝑎𝑘𝑒 𝑖𝑛 𝑔) 𝑋
(% 𝑁𝐷𝐹 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑒𝑒𝑑)
100
 
  
% NDF = Digestibility Coefficient X % NDF on DM basis of feed  
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Crude Protein 
AOAC (2002) official method 968.06: For determination of crude protein content 
For crude protein (CP) determination, the Dumas combustion method was used with a LECO FP 528 
for quantitative determination of nitrogen in the samples. The LECO was calibrated. A foil cup with 
sample weight of 0.1000g was placed in the carousel to be analysed. The calculation for lab values of 
crude protein in feed and faeces is done with the following formulae: 
% 𝐶𝑟𝑢𝑑𝑒 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 = % 𝑁𝑖𝑡𝑟𝑜𝑔𝑒𝑛 𝑋 𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 𝑜𝑓 6.25 
% CP digested is calculated with the following formulae: 
𝐷𝑖𝑔𝑒𝑠𝑡𝑖𝑏𝑖𝑙𝑖𝑡𝑦 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
=  
((𝐷𝑀 𝐼𝑛𝑡𝑎𝑘𝑒 𝑖𝑛 𝑔) 𝑋
(% 𝐶𝑃 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑒𝑒𝑑)
100 ) − (
(𝐷𝑀 𝐸𝑥𝑐𝑟𝑒𝑡𝑖𝑜𝑛 𝑖𝑛 𝑔 ) 𝑋
(% 𝐶𝑃 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑎𝑒𝑐𝑒𝑠)
100 )  
(𝐷𝑀 𝐼𝑛𝑡𝑎𝑘𝑒 𝑖𝑛 𝑔) 𝑋
(% 𝐶𝑃 𝑜𝑛 𝐷𝑀 𝑏𝑎𝑠𝑖𝑠 𝑜𝑓 𝑓𝑒𝑒𝑑)
100
 
 % CP = Digestibility Coefficient X % CP on DM basis of feed  
Nitrogen excretion was corrected for metabolic faecal nitrogen (MFN) and endogenous urinary 
nitrogen (EUN) according to McDonald et al. (1988) and nitrogen retention calculated with the 
following formulae: 
MFN = 5 g N/kg dry matter intake 
EUN = 0.18g N/kg BW0.75 
Nitrogen retention (g N/kg BW0.75/day) = 
[(𝑁𝑖𝑡𝑟𝑜𝑔𝑒𝑛 𝑖𝑛𝑡𝑎𝑘𝑒 − (𝑁𝑖𝑡𝑟𝑜𝑔𝑒𝑛 𝑖𝑛 𝑓𝑎𝑒𝑐𝑒𝑠 −  𝑀𝐹𝑁) − (𝑁𝑖𝑡𝑟𝑜𝑔𝑒𝑛 𝑖𝑛 𝑈𝑟𝑖𝑛𝑒
− 𝐸𝑈𝑁)]/𝐵𝑊0
.75/𝐷𝑎𝑦𝑠 
3.3.7 Statistical analysis 
Animals were regarded as random repetitions for the different diets and a univariate analysis of 
variance (Anova) was performed for apparent digestibility variables. Shapiro-Wilk test was performed 
to test for normality (Shapiro, 1965). Least squares means (LS-means) were computed and compared 
using pairwise p-values. A probability level of 5% was considered significant for all significance tests. 
Univariate analyses (Anova and regression) were performed using SAS software (Version 9.2, SAS 
Institute Inc, Cary, USA). 
3.3.8 Care and general husbandry of experimental animals 
Standard ethical norms of Stellenbosch University were used in this trial (SU-ACUD15-00082). The trial 
was conducted at Welgevallen Experimental Farm in Stellenbosch. Animals were housed in single 
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indoor pens for a controlled environment as well as protection against extreme weather conditions. 
Since animals were constricted, great care was taken to ensure animals had minimum levels of 
discomfort and were under constant surveillance during the day. General health was monitored by 
the student, animal technician and Professor LC Hoffman (distinguished Professor in the Animal 
Science Department at Stellenbosch University). When any abnormal conditions occurred, the animal 
received veterinary care. Two animals (one from each treatment) were taken out of the trial because 
they did not seem to adapt to the specific conditions as their intake was lower than the others. These 
animals were removed before they started losing weight. The data of the animals were not used in 
the statistical analysis. 
 
3.4 Results and discussion 
3.4.1 Animal weights 
At the start of the trial, starting weights were recorded for each animal. End weights were also taken 
when the trial finished. The average of the starting weight and end weight was used to calculate the 
average weight which was then used to determine metabolic weight for each animal (Average weight 
0.75). The results of the two treatment groups are summarised in Table 3.3.  
Table 3.3 Summary statistics (LSMeans ± SD) of Starting weight, End weight, Average weight and 
Metabolic weight of both the control and 135 mg/kg r-salbutamol treatment groups. 
Parameters measured 
 
Treatment 
P-value Control 135 mg S/kg 
(N=9) (N=9) 
Start weight (kg) 38.34 ± 2.80 37.60 ± 2.85 0.57 
End weight (kg) 39.70 ± 2.64 38.18 ± 2.79 0.24 
Average weight (kg) 39.02 ± 2.63 37.68 ± 2.67 0.29 
Metabolic weight (kg) 15.61 ± 0.79 15.20 ± 0.81 0.28 
  
No significant differences were found between the control and the treatment group. None of the 
weights from the two groups differed significantly from each other and can thus be considered as 
being statistically similar.  
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3.4.2 Proximate analysis values on faeces 
Proximate values (on a DM basis) were determined in the lab for the two treatments (Table 3.4). The 
percentages of organic matter (OM), neutral detergent fibre (NDF), crude protein (CP) and Ash were 
similar (P> 0.05) between treatments.  
Table 3.4 Summary statistics (LSMeans ± SD) of proximate analyses of faeces.   
  
Parameters measured 
*(%) 
Treatment 
P-value Control 135 mg S/kg 
(N=9) (N=9) 
Ash in faeces 14.33 ± 1.21 13.39 ± 0.89 0.06 
CP in faeces 15.05 ± 1.19 14.93 ± 1.16 0.82 
NDF in faeces 56.92 ± 2.70 58.09 ± 1.77 0.29 
DM of faeces 31.55 ± 3.95 33.87 ± 4.65 0.86 
*Values expressed as a percentage of total faeces weight  
 
3.4.3 Intake, excretion and digestion of nutrients 
In Table 3.5 the total kg of nutrients ingested, excreted and apparently digested calculated for organic 
matter, neutral detergent fibre (NDF) and crude protein (CP) is summarised for the whole 7-day trial 
period. Digestibility coefficients of NDF and CP as calculated in 3.3.6 under NDF and CP respectively 
are also included. No differences (P> 0.05) were observed between treatments. 
Table 3.5 Nutrients ingested, excreted and apparently digested on a DM basis for the 7-day period 
Nutrients Organic matter NDF Crude protein 
Parameters measured 
Treatment 
Control 135 mg S/kg Control 135 mg S/kg Control 135 mg S/kg 
(N=9) (N=9) (N=9) (N=9) (N=9) (N=9) 
Intake (kg per period) 9.33 ± 1.31 8.74 ± 1.15 3.00 ± 0.42 2.79 ± 0.37 1.46 ± 0.21 1.30 ± 0.17 
Excreted (kg per period) 2.52 ± 0.45 2.52 ± 0.57 1.42 ± 0.21 1.45 ± 0.34 0.39 ± 0.09 0.38 ± 0.09 
Apparently Digested (kg per period) 6.54 ± 1.09 6.22 ± 0.86 1.50 ± 0.40 1.35 ± 0.27 1.03 ± 0.18 0.93 ± 0.14 
Apparent Digestibility Coefficients   No value No value 0.49 ± 0.10 0.48 ± 0.09 0.71 ± 0.08 0.71 ± 0.05 
 a,b means in a row with different superscript letters differ (P≤ 0.05). 
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No differences in organic matter intake were observed with r-salbutamol supplementation. Excretion 
and digestion of organic matter too showed no differences between treatments. This is in line with 
other studies suggesting that beta-agonists have no effect on intake (Montgomery et al., 2009; Elam 
et al., 2009). Intake, excretion and digestion of both NDF and CP also showed no differences between 
treatments. This suggests that r-salbutamol supplementation in Dohne Merinos does not affect 
apparent digestibility when measured in kg per period. In accordance with this study, Fiems et al. 
(1991) reported that except for a decrease in crude fibre, nutrient digestibility coefficients were 
unaffected when sheep were treated with cimaterol. When sheep were treated with zilpaterol 
hydrochloride and ractopamine hydrochloride, digestibility coefficients were also similar (Lopez-
Carlos et al., 2010). 
3.4.4 Digestibility results: Organic Matter Disappearance, NDF, Crude Protein and Nitrogen retention 
Organic matter disappearance, NDF and crude protein, all on a dry matter basis were compared 
between the control and 135 mg/kg treatment group. To determine the % organic matter 
disappearance, % NDF and % crude protein, further calculations were conducted using the values of 
the proximate analysis calculated as described in 3.3.6. 
The calculated values for the 18 animals are summarised in Table 3.6. The four calculated values were 
compared with P ≤ 0.05 for both the control and 135 mg/kg r-salbutamol group.  
Table 3.6 Summary statistics (LSMeans ±SD) for % Organic Matter Disappearance, % NDF digested and 
% crude protein digested on a DM basis of the two treatment groups. 
Parameters measured 
 
Treatment 
P-value Control 135 mg S/kg 
(N=9) (N=9) 
% Organic Matter Disappearance 70.13 ± 7.51 71.27 ± 4.42 0.70 
% NDF 15.73 ± 3.32 15.45 ± 2.75 0.85 
% Crude Protein 11.08 ± 1.25 10.61 ± 0.71 0.60 
  
No significant differences were found between the control and treatment group of any parameters 
measured. R-salbutamol thus had no significant effect on % OMD, % NDF and % CP of Dohne Merino 
feedlot lambs. Only a few studies show significant effects of beta-agonists on digestibility coefficients; 
Walker and Drouillard (2010) reported and increased dry matter disappearance in vitro while Fiems et 
al., (1991) reported that only crude fibre decreased when sheep were treated with cimaterol. Most 
results are thus in line with this study with similar digestibility coefficients observed for neutral 
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detergent fibre (NDF), acid detergent fibre (ADF), crude protein (CP) and dry matter (DM) in feedlot 
lambs supplemented with both zilpaterol hydrochloride and ractopamine hydrochloride (Lopez-Carlos 
et al., 2010). Feedlot steers administered zilpaterol hydrochloride, ractopamine hydrochloride and 
cimaterol showed no differences in either CP or DM digestibility (Strydom et al., 2009). When lambs 
were administered beta-agonists such as cimaterol (Kim et al., 1989; Rikhardsson et al., 1991) and L-
644,969 (Li et al., 2000) no effects were observed on nutrient digestibility.  
3.4.5 Nitrogen retention 
In Table 3.7 the statistics for nitrogen intake, nitrogen excretion and nitrogen retention as calculated 
in 3.3.6 for the two groups of lambs receiving a feedlot diet, is summarised.  No differences (P> 0.05) 
were observed between treatments. 
Table 3.7 Summary statistics (LSMeans ±SD) for nitrogen retention of the two treatment groups. 
 
Parameters 
measured 
Treatment  
P-value 
 
Control 135 mg/kg 
(N=9) (N=9) 
N intake (g/day) 30.07 ± 4.23 26.78 ± 3.53 0.09 
Faecal N (% of N intake) 29.14 ± 7.99 28.84 ± 4.77 0.92 
Urinary N (% of N intake) 26.47 ± 8.78 33.27 ± 14.01 0.24 
Total N excreted (% of N intake) 55.62 ± 11.89 62.11 ± 14.37 0.31 
N retention (% of N intake) 62.22 ± 13.38 53.20 ± 19.53 0.27 
N retention (g/kg BW0.75) 1.15 ± 0.31 0.94 ± 0.29 0.16 
 
All parameters for nitrogen intake, excretion and retention are unaffected by r-salbutamol 
supplementation in Dohne Merino feedlot lambs. The similar N intake between treatments with the 
corresponding similarity of N excretion may suggest that there are no differences in nitrogen digestion 
and absorption between treatments (Nolte and Ferreira, 2004). With urinary nitrogen being similar, 
ammonia production in the gut of lambs from both treatments is also unaffected (Cole, 1999). 
Mammals have no endogenous urease which means excretion is the only means of removing urea 
from the body (Nolan, 1993). Therefore, the similar nitrogen retention may indicate that lambs from 
both treatments had the same nitrogen circulation and/or nitrogen utilization (Ørskov, 1992). Very 
few studies have been done on the effect beta-agonists have on nitrogen retention in sheep. However, 
Kim et al. (1989) found that cimaterol treated sheep had greater nitrogen retention due to reduced 
nitrogen loss in urine. Rikhardsson et al. (1991) also found an 18% increase in N retention due to a 
lower nitrogen excretion in urine when sheep were treated with cimaterol. This contradicts the 
current study which showed no differences in either N excretion in urine or N retention with r-
salbutamol supplementation in feedlot lambs. 
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3.5 Conclusion 
R-salbutamol supplementation had no effect on apparent digestibility in Dohne Merino feedlot lambs 
when administered at 135 mg r-salbutamol per kg of feed. All digestibility coefficients were similar. 
Higher doses of r-salbutamol may have an effect on apparent digestibility and further research is 
needed before recommendations can be made.  
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Chapter 4: 
The effect of r-salbutamol on growth, feed efficiency, carcass characteristics 
and meat quality of Dohne Merino feedlot lambs 
4.1 Abstract 
The effect the beta-agonist r-salbutamol has on feed efficiency, growth, carcass characteristics and 
meat quality of Dohne Merino feedlot lambs was evaluated. Fifty-six lambs were housed in individual 
pens indoor at Welgevallen experimental farm, Stellenbosch. Four treatments (14 animals per 
treatment) received a control diet or a diet containing one of three concentrations of r-salbutamol (S). 
The control were fed Meadow complete sheep finisher® pellets  and the three treatment groups were 
fed the same finisher pellets but with 110mg, 135mg and 160mg added r-salbutamol per kilogram 
feed (on an as fed basis), respectively. Lambs were blocked according to initial live weight and 
randomly allocated to treatments. The trial ran for 28 days during which wethers had ad libitum access 
to feed and quality water. After the trial, animals were slaughtered at a commercial abattoir where 
individual offal weights and primal cut weights were determined. A sample from the longissimus dorsi 
muscle from each animal was taken for physical measurements that included cooking loss, pH and 
shear force as well as for descriptive sensory analysis. A 3-rib cut (between the 9th and 12th rib) from 
the right side of each animal was taken for image analysis of both longissimus dorsi muscle area and 
fat thickness, the ratios of muscle to fat to bone of each animal were also determined. R-salbutamol 
at 160 mg/kg (on an as fed basis) improved the FCR significantly. Few significant differences were 
observed between offal and primal cuts from the different treatments. R-salbutamol also had no 
significant effect on either meat tenderness or carcass fat. The most pronounced effect r-salbutamol 
(160 mg S/kg diet) had on the carcass was the increase in % carcass muscle (P-value of 0.02).  
4.2 Introduction 
The livestock and meat industry are constantly looking for methods to promote efficient and rapid 
growth of the animals followed by improved carcass characteristics (Etherton, 2009; Beerman, 2009; 
Lopez-Carlos et al., 2010). This has led to extensive research on compounds such as beta-agonists that 
promote growth and improve carcass quality in meat producing species (Johnson and Chung, 2007). 
Beta-adrenergic receptors are present on almost all types of cells in mammalian tissue (Mersmann, 
1998). Although beta-agonists’ potency differ due to a variety of factors such as type of cell, dose, 
length of dose, type of beta-agonist, species and breed supplemented in, it has a range of positive 
effects on muscle and adipose tissue (Moody et al., 2000; NRC, 1994). Beta-agonists reduce adipose 
tissue and increase muscle mass by improving muscle metabolism in poultry, pigs, cattle and sheep 
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(Apple et al., 2008; Carr et al., 2005; Allen et al., 2009; Schaivone et al., 2004; Lopez-Carlos et al., 2010; 
Pringle et al., 1993; Parr et al., 2016). 
The beta-agonist zilpaterol hydrochloride has been used legally on feedlot cattle in South Africa and 
Mexico for more than ten years. It was also approved and has been used in USA feedlots since 2006 
(Avendano-Reyes et al., 2006; Shook et al., 2009). However, sales in the USA were suspended by the 
suppliers in 2013 due to reports of lameness in cattle. It has also been reported in numerous studies 
that zilpaterol hydrochloride has a negative effect on meat tenderness in beef (Rathmann et al., 2009; 
Strydom et al., 2011; Hope-Jones et al., 2012; Van Donkersgoed et al., 2014) and lamb meat (Dávila-
Ramírez et al., 2013). 
R-salbutamol is a purified derivative of albuterol (RS-salbutamol) which is used worldwide for 
treatment of respiratory disorders in humans. R-salbutamol has been investigated in feedlot cattle 
and a few scientific papers have also been published on its use in poultry, swine and feedlot cattle 
(Steenekamp, 2014). However, R-salbutamol has not been tested on feedlot sheep. It was found that 
r-salbutamol had a positive effect on carcass growth and composition in pigs (Merchant-Forde et al., 
2012).  
Dual purpose breeds such as Mutton Merino and Dohne Merino are favoured in South African feedlot 
production systems due to their better growth and being medium maturity types (Beukes et al., 2014). 
The Dohne Merino breed was thus chosen for this experiment. The aim of this study was to determine 
the effect three different concentrations of r-salbutamol have on the growth and carcass 
characteristics of feedlot lambs. 
4.3 Materials and methods 
4.3.1 Animals 
A total of 65 castrated Dohne Merino lambs at an average age of four months were obtained from a 
producer in the Malmesbury area of the Western Cape, South Africa.  Lambs with a weight range of 
28 to 32 kg were selected from a larger flock of the same producer. Lambs were housed at Welgevallen 
experimental Farm in Stellenbosch in indoor pens.  
The 65 Dohne Merino lambs were randomly divided into 4 group pens for adaptation to the group pen 
facilities. All animals were processed as per standard commercial practise: each lamb received an oral 
dose of Embavit® (Oral liquid vitamin supplement, Merial, New Zealand), Embamin® (Supplementary 
provision of trace elements, Merial, New Zealand), Ivomec® (Drench for sheep, Merial, New Zealand) 
and Valbazen® (Broad sectrum dewormer, Zoetis, USA) according to the suppliers’ directions while 
they were also inoculated against pasteurella (OBP® Pasteurella vaccine for sheep and goats, 
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Onderstepoort, RSA) and clostridium diseases (OBP® enterotoxaemia vaccine for sheep and goats, 
Onderstepoort, RSA). It should be noted that the lambs had not been shorn since birth. 
While in the group pens, lambs were fed commercial Meadow drought pellets for three days where-
after Meadow adaptation pellets were fed for another three days (Meadow Feeds®, PO Box 262, Paarl, 
7620,Tel: +27 21 807 8700). As soon as animals were adapted to the adaptation pellets, 56 animals 
were blocked according to their weight and selected to be moved to individual pens for the trial. These 
individual pens (1.1m X 1.8m) were constructed with fenced sides simulating a feeling of being in a 
group while individual feed intake could be measured accurately. In the individual pens, animals were 
adapted to Meadow complete finisher pellets. After 7 days, the animals were fully adapted to the 
pellets. Nutritional information of the different pellets is summarised in Table 4.1. Sheep were 
randomly assigned to four treatment groups within the sheep shed. The groups were: Standard 
Meadow sheep finisher as the control and Meadow sheep finisher with 160g/kg, 135g/kg and 110g/kg 
of R-salbutamol, respectively as the three treatments. Dosages were assigned to treatments according 
to the manufacturer’s recommendations and also a pilot study previously done on sheep. For 14 days 
the lambs received the standard Meadow sheep finisher pellets. On day 21 the trial started and 
animals were fed the four different treatment diets for 28 days before being slaughtered. No 
withdrawal of r-salbutamol is required. 
 
Table 4.1 Nutritional composition of Meadow Drought Cubes 10®, Meadow Complete Sheep 
Adaptation® and Meadow Complete Sheep Finisher® fed to the Dohne Merino wethers 
 Sheep drought pellets Sheep adaptation pellets Sheep finisher pellets  
Nutrient Quantity (g/kg) Max/Min 
Protein 100 155 120 Min 
Fat 25 25 25 Min 
Fat 70 Not specified 70 Max 
Fibre 120 Not specified 110 Min 
Fibre 200 200 200 Max 
Moisture 120 120 120 Max 
Calcium 3 Not specified Not specified Min 
Calcium 15 10 10 Max 
Phosphorus 3 2 2 Min 
Urea 10 2 10 Max 
 
Animals had ad libitum access to feed and clean quality water throughout the trial. Buckets of feed 
were weighed out for every animal at the start of each week. At the end of the week the refusals and 
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the feed left over in the feeding bucket were weighed back to determine weekly intake. Animals were 
fed 3 times a day; at 7am, 1pm and 7pm to stimulate regular feed intake.  
4.3.2 Care and general husbandry of experimental animals 
Standard ethical norms of Stellenbosch University were used in this trial (SU-ACUD15-00082). Animals 
were housed indoors for a controlled environment and protection against extreme weather 
conditions. General health was monitored by the student, animal technician and Professor LC Hoffman 
distinguished Professor in the Animal Science Department at Stellenbosch University. When any 
abnormal conditions occurred, animals received veterinary care; although none of these experimental 
animals required this care. 
4.3.3 Feedlot performance 
Feedlot performance of lambs were assessed by means of weekly gain of unfasted sheep (converted 
back to average daily gain), total weekly feed intake (converted to daily intake) and feed conversion 
ratio (calculated from both parameters mentioned). 
A feed sample of approximately 50 grams was taken from each 50 kg bag of the experimental feed fed 
to the animals which was then pooled and stored in an airtight container. Samples were chilled 
between 0-5°C before a proximate analysis was done on the feed. Feed was analysed for % moisture, 
% fat, % crude protein, % crude fibre and average gross energy. The results are summarised in Table 
4.2. 
Table 4.2 Nutrients of the experimental feed fed to all the animals (on a DM basis) 
Nutrients 
Moisture (%) 13.55 
Ash (%) 7.48 
Fat (%) 3.74 
Average Gross energy (MJ/kg)  17.99 
Average crude protein (%) 14.44 
Crude fibre (%) 14.4 
 
4.3.4 Carcass measurements at the abattoir 
After having received the experimental diets for 28 days, all lambs were slaughtered at a registered 
commercial abattoir (Tomis® abattoir, Hermon, Western Cape Province, SA) according to commercial 
slaughtering procedures. Electrical stimulation had been applied (110V for 50 seconds). Live mass 
before slaughter (With a 6 hour withdrawal period), warm carcass mass, cold carcass mass and carcass 
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classification data were obtained from the abattoir. Carcasses were classified according to South 
African legislation (Agricultural Product Standards Act, 1990. Act No.119 of 1990). Most carcasses had 
A2 classifications with odd animals reaching an A3 classification as indicated in Table 4.3. Weights 
were also taken of the head, feet, skin, pluck, omental fat and intestines of each animal. The head was 
removed from the spinal column at the occipito-atlantal junction while the feet were removed at the 
joint between the humerus and the scapula in the forelimbs and the joint between the femur and the 
tibia in the hind limbs. Carcasses were then chilled overnight at 0-5°C, cut up into primal cuts 
(shoulders, neck, back, ribs, fore legs, hind legs, and shins) by the same butcher as shown in Figure 4.1 
and weighed. The hind legs were removed at the position between the last lumbar and the first sacral 
vertebrae. The neck was removed at a right angle to the spine at the seventh cervical vertebrae. The 
front legs were removed by cutting the scapula and its associated muscles from the muscles on the 
thorax (Serratus ventralus). To remove the back, a cut was made along the spine from the seventh 
cervical vertebrae (where the neck was removed) all the way to the last lumbar vertebrae. A cut was 
then made from the 1st rib perpendicular to the spine on both sides, to remove the ribs, flank and 
shoulder. The thorax part was then divided at the first rib to split the shoulder and rib cut. The weight 
of the chilled kidneys and kidney fat were also recorded. 
Table 4.3 Carcass classification according to South African legislation of carcasses from each treatment 
Classification 
Treatment 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
n=14 n=14 n=14 n=14 
A2 12 13 13 13 
A3 2 1 1 1 
 
Figure  4.1 Diagram showing how the carcass was devided into primal cuts 
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4.3.5 Sample collection and analysis  
On the day after slaughter, the left and right side of the back was divided into 3 parts of which the loin 
and 3-rib cut was removed for analyses. The longissimus dorsi (LD) muscle of both loins were taken 
between the 2nd- 3rd last thoracic vertebrae and the 4th -5th lumbar vertebrae, vacuum packed and 
chilled between 0-5° for sensory analysis as well as cooking loss and Warner-Bratzler shear Force 
measurements. The 3-rib cut was removed between the 9th and 12th rib (includes the 9th, 10th and 11th 
rib) and extended from the spinal cord to where the plane of the ribs started to curve inwards. It was 
then frozen at -18 °C for image analysis and to determine the percentage bone, muscle and fat (carcass 
conformation) by dissection at a later stage. Subcutaneous fat was removed from the longissimus dorsi 
and categorised as fat where after the longissimus dorsi muscle was removed from the spine and rib 
bones and categorised as muscle. The bones were cleaned carefully, the remaining tissue divided into 
muscle and fat and added to the other muscle and fat tissue to be weighed. 
4.3.6 Image analysis 
A digital camera was secured on a tripod and a photo was taken of each of the 3-rib cuts on the 10th 
rib in the exact same manner. A ruler was also placed in the photo for accurate calibration with ImageJ. 
The fat thickness was measured 90° to the angle of the bone, where the fat attached to the centre 
point of the eye muscle (as illustrated in Figure 4.2) for each of the right 3-rib cuts. Eye muscle area 
was also determined for the right 3-rib cut of each animal using ImageJ. 
 
Figure 4.2: Graphic image of the 10th rib cut indicating the point of measurement of the fat thickness  
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4.3.7 Physical rib cut composition or carcass composition 
For determination of the muscle to fat to bone ratio, each of the 3-rib cuts was carefully dissected into 
muscle, fat and bone. The three different tissue types were weighed and expressed as a percentage 
of the three rib cut’s total weight. 
4.3.8 Physical measurements 
The pH of the four samples was measured for each of the eight replications. pH using a Crison pH 25 
portable pH meter (Lasec (Pty) Ltd, South Africa) was measured immediately after removal from the 
packaging before cooking for the DSA session. The pH meter was calibrated using the standard buffers 
(pH 4.0 and pH 7.0) provided by the manufacturer before each session.  
The cooking loss of the all the meat samples used for DSA were determined (AMSA, 1995). 
The Warner Bratzler shear force test as described by Honikel (1998) was used to measure the 
instrumental shear force of all cooked meat samples. Samples included the eight replications in the 
DSA as well as the six replications per treatment used for training the panellists. From the centre of 
each LD muscle two adjacent meat strips was cut parallel to the muscle fibre direction. These strips 
were then wrapped in aluminium foil and refrigerated at 4°C for 24 hours. A total of six rectangular 
cubes of 2 cm by 1 cm by 1 cm each were then cut from the respective meat strips. An Instron Universal 
Testing Machine (Instron UTM, Model2519-107) with a Warner-Bratzler fitting attached was used to 
test the force needed to shear the meat cubes perpendicular to the muscle fibre direction. The fitting 
used was a 1 mm thick blade with a V-notch and a cutting edge that was semi-circular. The Instron 
was operated with a compression load cell of 2 kN and the speed the shear was performed at was 
200mm/min. The shear force value was recorded in Newton and the mean of the six readings was 
used for statistical analysis. 
4.3.9 Sensory analysis 
Seven reference standards were prepared during the training phase of the descriptive sensory analysis 
(DSA; Geldenhuys et al., 2014). This included lamb meat, lamb fat, Karoo lamb meat, chicken breast 
meat, beef fillet, C-grade beef and lamb liver. These reference samples made it possible for panellists 
to calibrate their pallets for the different attributes. For the DSA of the experimental lambs’ LD 
muscles, eight samples from each treatment were specifically chosen; the LD muscle of the three 
heaviest as well as the three lightest animals (within each treatment) were removed from the sensory 
test to try and eliminate the effects the higher and lower intake of r-salbutamol may have had. The LD 
muscles of the six discarded carcasses were used to train the sensory panel.   
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Sensory analysis was conducted on carcasses of all four dietary treatments. The two LD muscles from 
each carcass was treated as an entity and cooked in the same oven bag (Glad®, Clorox Africa (PTY) 
LTD). Throughout the DSA no additives or seasoning were added to the meat samples during the 
cooking. The meat samples and oven bags were placed on a stainless steel grid fixed to a roasting pan. 
Thermocouple probes connected to a handheld digital temperature monitor (Hanna Instruments, 
South Africa) were carefully inserted in the centre of each meat sample. The samples were then placed 
in a conventional oven (Defy, Model 835) already preheated to 160°C and removed when an internal 
temperature of 72°C was reached. After it was left to cool for 10 minutes, the LD was cut up in 1 cm3 
cubes and individually wrapped in aluminium foil. Two cubes of each sample were placed in coded 
glass ramekins. The ramekins were placed in a preheated industrial oven (Hobart, France) at 100°C for 
10 minutes and served to the panellists immediately thereafter.  
A panel of nine judges experienced in meat DSA, were selected for the analysis. The panel were trained 
according to the “Guidelines for meat sensory analyses” (AMSA, 1995) using the techniques for 
generic descriptive analysis as described by Lawless and Heymann, (2010). The panel had six training 
sessions where they received 1 cm3 cubes of meat from both the four treatments and the seven 
reference samples. Reference samples were chosen to illustrate the aromas and flavour normally 
associated with lamb meat. The attributes and definitions for each as defined by the panel are 
described in Table 4.4. Panellists were seated in individual booths fitted with computers containing 
the Compusense five (Compusense, Guelph, Canada) software program. The four treatments were 
received in a complete randomised order. DSA lasted for 3 days of which two sessions were on the 
first day and 3 sessions on each of the second and third day. Each session had two cubes from a carcass 
of each treatment. An unstructured line scale was used to analyse the respective attributes. Zero on 
the scale indicated low intensity while 100 indicated high intensity (AMSA, 1995). 
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Table 4.4 Definition and scale of each attribute used for descriptive sensory analysis of the wether 
meat 
Sensory attribute Description Scale 
Lamb meat 
aroma 
Aroma associated with cooked lean muscle 
from lamb meat 
0- Extremely bland/100- 
Extremely intense 
Fatty aroma Aroma associated with cooked lamb fat 0- Extremely bland/100- 
Extremely intense 
Beef aroma Aroma associated with cooked lean muscle 
from beef meat 
0- Extremely bland/100- 
Extremely intense 
Sweet-associated 
aroma 
Sweet aroma of sugar 0- Extremely bland/100- 
Extremely intense 
Fatty flavour Flavour associated with cooked lamb fat 0- Extremely bland/100- 
Extremely intense 
Lamb meat 
flavour 
Flavour associated with cooked lean muscle 
from lamb meat 
0- Extremely bland/100- 
Extremely intense 
Beef meat 
flavour  
Flavour associated with cooked lean muscle 
from beef meat 
0- Extremely bland/100- 
Extremely intense 
Sweet-associated 
flavour 
Flavour of sugar 0- Extremely bland/100- 
Extremely intense 
Metallic flavour Flavour similar to coins, ferro-sulphate of 
liver 
0- Extremely bland/100- 
Extremely intense 
Sustained 
juiciness 
The level of juiciness perceived after 5 
chews with molar teeth 
0- Extremely bland/100- 
Extremely intense 
First bite 
tenderness 
The level of tenderness with the first bite 0- Extremely bland/100- 
Extremely intense 
Residue The amount of residue left in the mouth 
after 10 chews 
0- Extremely bland/100- 
Extremely intense 
 
4.3.10 Statistical analysis 
The trial experimental design was a randomised block with the four diets replicated at random within 
14 blocks of animals of similar weight 14 days before the onset of the trial. For the growth data, 
average daily gain (ADG in kg/day) for each animal was estimated using the slope of a linear regression 
of weight change (kg) over the trial period (days). Feed conversion ratio (FCR) was calculated as the 
quotient of DMI over the trial period (kg/day) and ADG (kg/day). The data for individual or primal cuts 
were expressed as a percentage of the cold carcass weight. For carcass conformation and image 
analysis the right three rib cuts were used.  
The trial experimental design for the sensory analysis and corresponding physical measurements 
consisted of a randomised block design with four treatments and a selected eight of the fourteen 
replications. For sensory analysis panel performance was monitored using Panelcheck software 
(Version 1.4.0, Nofima; Tromsø, Norway). Sensory analysis data was pre-processed to test for panel 
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reliability using a model that includes panellist, session (corresponding to blocks) and treatment 
effects and interactions (Næs et al. 2010) indicated by the following equation: 
yijk = µ + bi + tj  + btij + pk + bpik + tpjk + ɛijk 
where terms of the model are defined as µ, the overall mean, bi the effect due to session (block), tj 
the effect due to treatment, btij the interaction effect between session and treatment, pk the effect 
due to panellist, bpik and tpjk the interaction effects respectively between panellist and session or 
treatment and εijk, the random error associated with the response of panellist k on treatment j in 
session i. 
 The Shapiro-Wilk test for normality was performed on the standardised residuals from the model. If 
there was significant deviation from normality, outliers were removed when the standardised residual 
for an observation deviated more than three standard deviations from the model value.  Following 
the confirmation of panel reliability and normality, subsequent statistical analyses on sensory data 
were conducted on means over panellists. 
Univariate analysis of variance (Anova) was performed on data for intake of r-salbutamol as main 
effect, data of individual cuts as well as sensory and physical variables according to the model for the 
experimental design indicated by the following equation: 
yij = µ + bi + tj + ɛij 
Where terms of the model are defined as µ, the overall mean, bi the effect due to block, tj the effect 
due to treatment and εij, the random error associated with the response on treatment j in block i. 
For growth data (DMI, ADG and FCR) and carcass data a covariance analysis was performed using 
animal weight at the start of the trial as covariate (instead of block effect) to adjust for initial weight 
differences between individual animals. 
Shapiro-Wilk test was performed to test for normality (Shapiro, 1965). As FCR distribution deviated 
from normality, an inverse transformation was done to improve normality.  Least squares means (LS-
means) were computed and compared using pairwise p-values. A probability level of 5% was 
considered significant for all significance tests. Univariate analyses (Anova and regression) were 
performed using SAS software (Version 9.2, SAS Institute Inc, Cary, USA). 
 
Stellenbosch University  https://scholar.sun.ac.za
56 
 
4.4 Results and Discussion 
4.4.1 Feedlot performance: Average daily gain, Dry matter intake and feed conversion ratio 
In Table 4.5, the growth data is summarised for the 28 day feeding period of the four treatment 
groups.  
 
Table 4.5 Summary statistics (LSMeans ± SD) of dry matter intake (DM intake), average daily gain 
(ADG), average daily gain calculated from the slope (ADG from slope), feed conversion ratio (FCR) and 
feed conversion ratio calculated from the slope (FCR from slope) of the four treatment diets containing 
different concentrations of r-salbutamol.  
  
Parameter measured  
  
Treatment 
P-value Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=14) 
DM intake (kg/day) 1.81 ± 0.26 1.76 ± 0.19 1.82 ± 0.18 1.83 ± 0.16 0.74 
ADG (kg) 0.29 ± 0.07 0.31 ± 0.08 0.32 ± 0.06 0.33 ± 0.05 0.64 
ADG from slope (kg) 0.29 ± 0.07 0.31 ± 0.07 0.33 ± 0.06 0.33 ± 0.05 0.50 
FCR (kg) 6.50ᵃ ± 1.33 5.95ᵃᵇ ± 1.25 5.76ᵃᵇ ± 0.65 5.70ᵇ ± 0.92 0.03 
FCR from slope (kg) 6.43ᵃ ± 1.21 5.91ᵃᵇ ± 1.12 5.65ᵇ ± 0.59 5.64ᵇ ± 0.85 0.01 
a,b means in a row with different superscript letters differ (P≤ 0.05). 
Lambs fed 160 mg S/kg r-salbutamol required significantly less feed per kg weight gain (5.70 ± 0.92 kg) 
than the control (6.5 ± 1.33 kg).  
Feed conversion ratios calculated from the slope also showed significant differences with both 135 
and 160 mg S/kg performing significantly better than the control group (Table 4.4). This indicates that 
in r-salbutamol treated groups, less feed was required (5.65 ± 0.59kg/5.64 ± 0.85kg) for each kg body 
weight gain compared to the control group (6.43 ± 1.12kg). This is in accordance with results from 
others who also found an improved FCR in feedlot cattle and sheep treated with the beta-agonist 
zilpaterol hydrochloride (Vasconcelos et al., 2008; Elam et al., 2009; Montgomery et al., 2009; Lopez-
Carlos et al., 2010; Salinas-Chavira et al., 2011). R-salbutamol also showed improved FCR when 
administered in pigs (Marchant-Forde et al., 2012). When r-salbutamol and zilpaterol hydrochloride 
were compared by Steenekamp (2014) in feedlot bulls however, no significant improvements in FCR 
was found between the beta-agonist fed bulls and the control. 
R-salbutamol had no significant effect on DM intake, ADG and ADG calculated from the slope which 
agreed with previous studies with regard to DM intake (Montgomery et al., 2009; Elam et al., 2009). 
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However, in studies with other beta-agonists on cattle, sheep and also in pigs treated specifically with 
r-salbutamol, an increased ADG was observed (Vasconcelos et al., 2008; Montgomery et al., 2009; 
Elam et al., 2009; Marchant-Forde et al., 2012; Lopez-Carlos et al., 2010; Salinas-Chavira et al., 2006). 
4.4.2 Feed Conversion Ratio and Average Daily Gain calculations with actual r-salbutamol intake as 
main effect  
As an addition to the normal growth and performance data with treatment as main effect (Table 4.5), 
the dietary treatments were ignored and individual FCR and ADG values were also recalculated with 
the actual intake of the of active ingredient, r-salbutamol. Thereafter, the wethers were re-
categorised as zero, low, medium, and high. The control group was taken as zero r-salbutamol and for 
the other 3 groups, the total r-salbutamol was according to the intake classified as low with a range 
of 4299.79<x<6082.01mg intake of r-salbutamol, medium with a range of 6088.23<x<7446.88mg 
intake of r-salbutamol and high with a range of 7467.68<x<9814.56mg intake of r-salbutamol. This 
method of calculation was used as variation in feed intake, and therefor of r-salbutamol, was high 
amongst and within the treatments. This variation made groups formed based on equal intervals too 
uneven for statistical analysis. The ranges are thus unequal to have balanced groups (n=14). Data 
summarised in Table 4.6. 
Table 4.6 Summary statistics (LSMeans ± SD) of average daily gain (ADG) and feed conversion ratio 
(FCR) calculations with mg r-salbutamol intake as main effect 
Parameter measured 
  
Treatment 
P-value Zero Low Medium High 
(n=14) (n=14) (n=14) (n=14) 
ADG (kg/day)  0.29 ± 0.07 0.29 ± 0.07 0.33 ± 0.04 0.34 ± 0.07 0.12 
FCR (kg feed/kg weight gain) 6.48 ± 1.85 6.27 ± 3.56 6.53 ± 2.56 6.17 ± 2.08 0.98 
No significant differences were observed for ADG and FCR between groups with different intake levels 
of the active ingredient, r-salbutamol. Improved ADG and FCR was expected as the intake of r-
salbutamol increased. The results are in contrast with results from other authors that have 
administered beta-agonists to feedlot lambs. When feedlot lambs were treated with zilpaterol 
hydrochloride and ractopamine hydrochloride in a comparative study, both beta-agonists showed 
improved ADG and FCR compared to a control group (Lopez-Carlos et al., 2010). Other authors 
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suggested the same improvement in beta-agonist supplemented lambs (Salinas-Chavira et al., 2006). 
R-salbutamol treated pigs also had an improved ADG and FCR (Marchant-Forde et al., 2012). 
4.4.3 Carcass and slaughtering data 
In Table 4.7 the carcass data is summarised. Feeding of r-salbutamol had no effect (p>0.05) on any of 
the slaughter parameters. 
 
Table 4.7 Summary statistics (LSMeans ± SD) of live weight at slaughter, warm carcass mass, cold 
carcass mass, dressing out percentage and warm carcass pH45 (45 minutes post mortem ) of the four 
treatment groups. 
Parameters measured 
  
Treatment 
P-
value 
Control 
110 mg 
S/kg 
135 mg S/kg 
160 mg 
S/kg 
(N=14) (N=14) (N=14) (N=14) 
Live weight before slaughter 
(kg)  
42.70 ± 
4.52 
43.66 ± 
3.82 
42.70 ± 2.89 
43.89 ± 
3.09 
0.22 
Warm Carcass mass (kg) 
21.36 ± 
2.29 
21.89 ± 
2.04 
21.93 ± 1.32 
21.99 ± 
1.89 
0.19 
Cold Carcass mass (kg) 
20.71 ± 
2.24 
21.29 ± 
2.01 
21.27 ± 1.28 
21.33 ± 
1.84 
0.21 
Dressing out percentage  48.5 ± 2.02 48.8 ± 1.78 48.4 ± 1.37 48.6 ± 2.00 0.94 
pH45 6.34ᵇ ± 0.41 5.96ᶜ ± 0.43 
6.45ᵃᵇ ± 
0.44 
6.76ᵃ ± 0.50 
<0.0
1 
a,b means in a row with different superscript letters differ (P≤ 0.05). 
Beta-agonist supplementation normally results in heavier carcass mass and better dressing out 
percentage (Moody et al., 2000). The extent of the response however, depends on the type of beta-
agonist used and is influenced by factors such as age, sex, species, breed and diet. When ractopamine 
hydrochloride was administered in sheep, none of the carcass characteristics improved (Robles-
Estrada et al., 2009). In another study, carcass characteristics such as warm carcass mass and dressing 
out percentage increased linearly as ractopamine hydrochloride increased (Lopez-Carlos et al., 2010). 
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Felix et al. (2005) also showed that results of carcass characteristics in sheep are inconsistent where 
zilpaterol hydrochloride had no effect on carcass characteristics of Pelibuey lambs.  
Also, when feedlot bulls were supplemented with r-salbutamol, no effect on carcass characteristics 
was observed (Steenekamp, 2014). However, an improved warm carcass mass and dressing out 
percentage was observed in pigs when treated with r-salbutamol (Marchant-Forde et al., 2012).  
4.4.4 Data of individual cuts and organs for determination of muscle distribution in the carcass 
In Table 4.8 the data of the different body parts and organs collected on the day of slaughter are 
summarised. The values are expressed as a percentage of the animal’s live weight immediately before 
slaughter. In Table 4.9, the data of the primal cuts taken 24 hours after slaughter is summarised.  
Table 4.8 Summary statistics (LSMeans ± SD) of different body parts expressed as a percentage of live 
weight of wethers fed different levels of r-salbutamol (S). 
Parameters measured 
(%)* 
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(N=14) (N=14) (N=14) (N=14) 
Head 4.94ᵇ ± 0.53 5.26ᵃ ± 0.44 5.23ᵃᵇ ± 0.27 5.06ᵃᵇ ± 0.31 0.14 
Feet 2.59 ± 0.26 2.57 ± 0.23 2.67 ± 0.26 2.55 ± 0.14 0.55 
Skin 10.19 ± 0.75 10.00 ± 0.72 9.73 ± 0.99 9.77 ± 0.62 0.38 
Pluck 4.63ᵇ ± 0.29 4.65ᵃᵇ ± 0.31 4.88ᵃ ± 0.31 4.79ᵃᵇ ± 0.34 0.12 
Intestines 21.24 ± 1.41 20.84 ± 1.83 20.61 ± 1.27 20.32 ± 1.70 0.47 
Omental fat 1.27ᵃᵇ ± 0.37 1.15ᵇ ± 0.31 1.30ᵃᵇ ± 0.17 1.40ᵃ ± 0.24 0.17 
a,b means in a row with different superscript letters differ (P< 0.05). 
* The values are expressed as a percentage of the live weight. 
The effect of beta-agonists on offal is rarely studied as it has little value compared to the rest of the 
carcass. It was found however, that beta-agonists including zilpaterol hydrochloride has no effect on 
non-carcass components in sheep when expressed as a percentage of live weight (Li et al., 2000; 
Aguilera-Soto et al., 2008). This is due to the low hypertrophic effect of beta-agonists on visceral 
organs (Li et al., 2000). The type, number and activation of receptors differ in different tissues and the 
largest concentration is found in skeletal muscle where hypertrophic action occurs. In a study with 
ewe lambs, zilpaterol hydrochloride also had no effect on internal fat of the carcass (Macias-Cruz et 
al., 2010).  
In this study, from the different body parts and organs, only the percentages of the head, pluck and 
omental fat differed significantly between treatment groups. The percentage omental fat was larger 
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for the group treated with the highest concentration of r-salbutamol. This is in contrast with previous 
beta-agonist studies, which had no effect on non-carcass components and also tend to decrease fat 
in the carcass. As in other studies, no further significant differences between treatment groups were 
observed for the percentage weights of the intestines, skin and feet. 
 
Table 4.9 Summary statistics (LSMeans ± SD) of different primal cuts as a percentage of cold carcass 
mass of wethers fed different levels of r-salbutamol (S). 
Parameter measured 
(%)* 
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(N=14) (N=14) (N=14) (N=14) 
Neck 4.15ᵇ ± 0.52 4.61ᵃ ± 0.41 4.10ᵇ ± 0.41 4.24ᵇ ± 0.32 0.01 
Shoulders 16.19ᵃ ± 1.66 14.82ᵇ ± 0.95 15.73ᵃ ± 0.77 15.48ᵃᵇ ± 0.97 0.02 
Forelegs 13.88 ± 1.38 14.41 ± 1.09 14.10 ± 1.07 14.28 ± 0.83 0.61 
Ribs 10.33 ± 0.99 10.59 ± 0.65 10.37 ± 0.71 10.34 ± 0.59 0.77 
Back 18.69ᵃ ± 0.82 17.82ᵇ ± 0.62 18.25ᵃᵇ ± 0.64 18.52ᵃ ± 0.50 0.01 
Hind legs 31.95 ± 1.03 32.56 ± 1.17 32.76 ± 1.33 32.27 ± 1.16 0.30 
Shins 3.14ᵇ ± 0.33 3.27ᵃᵇ ± 0.32 3.46ᵃ ± 0.16 3.47ᵃ ± 0.24 0.01 
Kidneys 0.61 ± 0.08 0.61 ± 0.07 0.64 ± 0.05 0.62 ± 0.06 0.68 
Kidney fat 2.53 ± 0.75 2.31 ± 2.31 2.22 ± 2.22 2.21 ± 2.21 0.50 
a,b means in a row with different superscript letters differ (P≤ 0.05). 
*The values are expressed as a percentage of cold carcass mass 
Of the primal cuts, only percentage weights of the shoulders, neck, back and shins showed differences 
(P≤0.05) between treatment groups. The other primal cuts and organs such as kidneys, ribs, forelegs, 
hind legs and kidney fat did not differ (P> 0.05) between treatments. Percentage shoulder of the 
control group was the heaviest followed by the 135mg S/kg group. These two groups did not differ 
(P> 0.05) from each other but both groups differed from the 110 mg S/kg group which had the lightest 
percentage shoulders. The percentage neck was the heaviest for the 110 mg S/kg group and differed 
significantly from the other three treatment groups. Zilpaterol hydrochloride was shown to decrease 
forequarter % but increase hind quarter % in a study on feedlot lambs as the Control groups had 
greater shoulder and neck percentages than the zilpaterol treated lambs (Macias-cruz et al., 2010). 
However, R-salbutamol in this study did not decrease the % shoulders and in contrast increased the 
% neck when administered in low concentrations (135mg S/kg). It also had no effect on the hind 
quarters as hind leg yields did not differ across treatment groups. Percentage shins was the heaviest 
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for the 160 mg S/kg group, followed by the 135 mg S/kg group; both groups differed significantly from 
the control. The % back of the control group and 160 mg S/kg group did not differ (p >0.05) and was 
the heaviest across the four treatment groups. Both groups differed significantly from the 110 mg S/kg 
group which had the lightest % back. Zilpaterol hydrochloride treated feedlot lambs had similar 
percentages of average loin yields as the control group according to Macias-cruz et al, (2010); a result 
similar to the r-salbutamol in the higher concentrations in this investigation. The 110 mg S/kg group 
seem to increase the percentage of less valuable cuts such as the neck while it decreases the 
percentage of more usable and valuable cuts such as the shoulders and back. With higher 
concentrations of r-salbutamol this phenomenon seems to disappear as the 160 mg S/kg group and 
135mg S/kg group did not show any differences in the % shoulders and back compared to the control 
group (p >0.05). 
4.4.5 Image analysis of eye muscle area and fat thickness 
Table 4.10 Summary statistics (LSMeans ± SD) for image analysis of eye muscle (m. longissimus muscle) 
area and subcutaneous fat thickness (in cm) of the 3-rib cut. No significant differences in eye muscle 
area and fat thickness were found between treatment groups. 
Parameter measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=13) 
Eye muscle area (cm²) 24.26 ± 3.91 26.89 ± 4.40 26.69 ± 3.71 24.57 ± 2.87 0.14 
Fat thickness right (cm) 0.41 ± 0.12 0.46 ± 0.12 0.41 ± 0.12 0.41 ± 0.20 0.64 
 
Many authors found an increase in eye muscle area with beta-agonist supplementation (Lopez-Carlos 
et al., 2010; Macias-Cruz et al., 2010). As discussed previously beta-agonists tend to decrease carcass 
fat; subcutaneous fat thickness was decreased in feedlot lambs when administered both zilpaterol 
hydrochloride and ractopamine hydrochloride (Lopez-Carlos et al., 2010). In contrast, no significant 
effect on subcutaneous fat thickness was found when feedlot bulls were supplemented with r-
salbutamol (Steenekamp, 2014). In this study the same lack of an effect on subcutaneous fat was 
observed in feedlot lambs with r-salbutamol treatment. 
4.4.6 Carcass composition (percentage muscle, bone and fat) 
In Table 4.11 the carcass conformation data of the right 3-rib cut (taken between the 9th and 12th rib) 
is summarised.  
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Table 4.11 Summary statistics (LSMeans ± SD) of carcass composition (percentage muscle to bone to 
fat) of the 3-rib cut. 
Parameter measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=13) 
Percentage muscle  34.67ᵇ ± 3.31 36.42ᵃᵇ ± 3.36 36.55ᵃᵇ ± 2.71 37.37ᵃ ± 2.58 0.02 
Percentage fat  33.84ᵃᵇ ± 4.55 32.30ᵇ ± 5.07 35.01ᵃᵇ ± 3.60 36.33ᵃ ± 4.51 0.02 
Percentage bone  31.49ᵃ ± 3.36 31.28ᵃᵇ ± 4.00 28.44ᵇᶜ ± 4.45 26.30ᶜ ± 3.56 <0.01 
a,b means in a row with different superscript letters differ (P≤ 0.05). 
Percentage muscle is significantly higher for the 160 mg S/kg group compared to the control group 
indicating that beta-agonist supplementation has an overall effect on skeletal muscle in the wethers. 
Beta-agonists can stimulate hypertrophy through decreased protein degradation and increased 
protein synthesis depending on the type of beta-agonists, the breed, species and also the nutritional 
status of the animal (Mersmann, 1998). In a study comparing zilpaterol hydrochloride and 
ractopamine hydrochloride on feedlot lambs, both beta-agonists improved muscularity (Lopez-Carlos 
et al., 2010). When r-salbutamol was administered in feedlot bulls it not only had larger percentage 
muscle than the control group but also a larger percentage muscle than zilpaterol hydrochloride 
treated bulls (Steenekamp, 2014). This is all in accordance with the results of the current study which 
suggests that r-salbutamol is an effective agent in skeletal muscle metabolism.  
Percentage fat was also the highest for the 160 mg S/kg treatment group and differed significantly 
from the 110 mg S/kg group. Although both the 135 mg S/kg and the 160 mg S/kg group had a larger 
fat percentage than the control group, it did not differ significantly. This means that percentage fat is 
decreased in low concentrations of r-salbutamol but the effect disappears as the concentration 
increases. Only the 110 mg S/kg can thus be seen as having a significant effect on lipid metabolism. 
This contradicts previous studies which suggest reduced fat in sheep carcasses with beta-agonist 
supplementation (Rikhardsson et al., 1991; Salinas-Chavira et al., 2004). R-salbutamol administered in 
feedlot bulls also showed lower proportions of internal carcass fat and a lower percentage fat in the 
longissimus dorsi muscle compared to control bulls (Steenekamp, 2014). The lower percentage fat 
suggests that r-salbutamol is an effective lipolysis agent in feedlot bulls. In feedlot sheep however, 
this seems not to be the case although it could be argued that the results of this investigation are 
inconclusive and thus warrants further research. 
Stellenbosch University  https://scholar.sun.ac.za
63 
 
With the percentage bone the 160 mg S/kg group again performed the best with the lowest 
percentage followed by the 135 mg S/kg group; these groups did not differ significantly. The 160 mg 
S/kg group differed significantly however from the control as well as the 110 mg S/kg group. The 135 
mg S/kg group also had significantly lower percentage bone than the control group. The control 
group performed the worst with the largest percentage bone. This means that r-salbutamol can 
decrease percentage bone in the carcass resulting in more usable and valuable meat in lamb 
carcasses.  
4.4.7 Physical measurements 
Summarised in Table 4.12 are the pH values of the uncooked samples of the longissimus dorsi muscle, 
the percentage cooking loss, and also the average shear force value of six repetitions measured on 
the cooked samples.  
Table 4.12 Summary statistics (LSMeans ± SD) of muscle pH before cooking, percentage cooking loss 
and average shear force values. 
    
Parameter measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=14) 
pH Raw 5.73 ± 0.12 5.69 ± 0.10 5.65 ± 0.06 5.68 ± 0.10 0.37 
% Cooking loss 31.79 ± 8.34 30.04 ± 8.36 29.88 ± 4.91 31.18 ± 8.55 0.95 
Instron (N) 25.29 ± 9.41 29.59 ± 5.57 31.27 ± 10.56 29.32 ± 3.82 0.49 
a,b means in a row with different superscript letters differ (P< 0.05). 
No differences (P >0.05) in the pH of the raw muscle, the average shear force value (N) nor the 
percentage cooking loss were observed. In a study on feedlot bulls, a trend was observed where r-
salbutamol treated bulls had slower pH declines than zilpaterol hydrochloride treated bulls. This was 
suggested to be due to differences in muscle energy status possibly due to differences in stress 
responsiveness of zilpaterol supplemented bulls compared to r-salbutamol supplemented bulls 
(Steenekamp, 2014). Unfortunately, pH decline over time during the chilling process was not 
measured in this investigation and may warrant further research. 
Beta-agonists have been reported by many authors to increase toughness of meat, especially beta₂-
agonists such as zilpaterol hydrochloride which has a pronounced effect on muscle metabolism 
(Leheska et al., 2009; Strydom et al., 2009; Rathmann et al., 2009; Strydom et al., 2011). This is due to 
changes in muscle fibre size and proportions linked to changes in proteolytic activity (Dunshea et al., 
2005). Steenekamp (2014) also reported higher shear force values of feedlot bulls treated with 
zilpaterol hydrochloride when compared to control and r-salbutamol treated bulls although the R-
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salbutamol treated bulls did not differ in shear force values from the control group. This was suggested 
to be due to the more prominent effect r-salbutamol has on lipolysis and the minor effect it has on 
muscle metabolism (Steenekamp, 2014). This is in accordance with the current study where no 
increase in shear force values of r-salbutamol treated feedlot lambs were noted, regardless of the 
concentration of beta-agonist fed/consumed. 
4.4.8 Descriptive sensory analysis  
In Table 4.13 the statistics of the sensory attributes are summarised as scored by the nine judges on 
the descriptive sensory panel. Significant differences (P<0.05) were only noted for the attributes 
metallic taste and sustained juiciness. 
Table 4.13 LSMeans ± SD of Sensory data scored on a scale from 0-100 with zero representing low 
intensity and 100 representing high intensity. 
Parameter measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=8) (n=8) (n=8) (n=8) 
Lamb meat aroma 59.3 ± 0.8 59.1 ± 0.9 59.3 ± 1.0 59.2 ± 1.0 0.95 
Beefy aroma 50.2 ± 1.4 50.3 ± 1.2 50.4 ± 0.5 50.5 ± 1.3 0.95 
Sweet associated aroma 10.1 ± 0.1 10.2 ± 0.2 10.3 ± 0.3 10.3 ± 0.3 0.63 
Fatty aroma 10.1 ± 0.3 10.1 ± 0.2 9.9 ± 0.3 10.1 ± 0.3 0.29 
Initial juiciness 41.6 ± 4.9 39.8 ± 3.5 41.7 ± 3.6 41.2 ± 3.7 0.76 
Lamb meat flavour 59.5 ± 0.9 59.5 ± 0.8 59.7 ± 0.5 59.0 ± 0.8 0.32 
Beefy flavour 50.4 ± 0.8 50.5 ± 0.6 50.2 ± 0.6 50.5 ± 0.5 0.77 
Sweet associated flavour 10.3 ± 0.2 10.2 ± 0.2 10.3 ± 0.3 10.1 ± 0.1 0.25 
Fatty Flavour 10.4 ± 0.6 10.7 ± 0.9 10.2 ± 0.8 9.9 ± 0.6 0.30 
Metallic Taste 0.9ᵇ ± 0.9 1.9ᵃᵇ ± 1.3 2.3ᵃ ± 1.2 2.0ᵃᵇ ± 1.5 0.04 
Sustained juiciness 43.2ᵃᵇ ± 4.4 39.1ᵇ ± 3.7 41.4ᵃᵇ ± 3.0 43.3ᵃ ± 5.1 0.03 
Tenderness 53.0 ± 8.9 47.2 ± 8.7 52.9 ± 8.2 46.8 ± 7.6 0.28 
Residue 26.9 ± 5.0 29.4 ± 7.1 27.7 ± 5.4 29.7 ± 5.4 0.73 
a,b means in a row with different superscript letters differ (P< 0.05). 
A significant difference was found in metallic taste between the 135 mg S/kg group (higher value) and 
the control group. However, the metallic flavour was not very distinct as it was scored 2.3 ± 1.17 on a 
scale from zero to 100. The 160 mg S/kg group had a significantly higher (P<0.05) sustained juiciness 
than the 110 mg S/kg group. However, there were no significant differences in sustained juiciness 
between the control group, the 135 mg/kg r-salbutamol group and the 160 mg/kg r-salbutamol group. 
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In low concentrations, r-salbutamol can reduce sustained juiciness making meat seem dry when eaten. 
When administered in higher concentrations however, this is not the case as both the 135 and 160 mg 
S/kg treatment group has higher sustained juiciness than the control, although not significant. This 
could have been due to the higher fat content or percentage fat in the 135 and 160 mg S/kg groups. 
The sensory analysis indicates that meat not only has similar shear force values (Table 3.8) but the 
perceived toughness when eaten is also the same. Perceived toughness can sometimes be influenced 
by other factors such as juiciness. This is not the case with r-salbutamol and no differences in 
toughness or residue could be detected by the sensory panel. It is interesting that the other attributes 
especially tenderness and residue showed no differences (P>0.05) between treatment groups. The 
use of B-agonists and other growth stimulants are frequently associated with increased toughness 
(Montgomery et al., 2009; Elam et al., 2009).  
4.5 Conclusions 
In this study, r-salbutamol seemed most effective in Dohne Merinos when administered in the highest 
concentration of 160 mg S/kg. This group had a better feed conversion ratio compared to the control 
but no effects were observed on daily gain and lipid metabolism as other beta-agonists tend to have. 
R-salbutamol did not affect carcass characteristics at any concentration and effects on offal and primal 
cuts were minimal. The most prominent effect on offal and primal cuts were the lack of difference in 
omental as well as kidney fat suggesting that r-salbutamol may have reduced effect on fat in the 
abdominal area. Furthermore, no differences were observed in percentage carcass fat and 
subcutaneous fat thickness which suggests that r-salbutamol was ineffective in lipid metabolism in 
this study. Percentage muscle in the 160 mg S/kg group was higher than the control while percentage 
bone was lower. R-salbutamol is thus effective in muscle metabolism. Beta-receptor numbers for 
younger animals are often low and can increase in number as an animal ages. The fact that lambs in 
this study were still very young could thus explain the reduced effect on fat and lipid metabolism in 
Dohne Merino lambs. R-salbutamol, other than other beta-agonists tested has no effect on shear force 
of meat or perceived toughness as tested for in descriptive sensory analysis when administered in any 
concentration. This suggests that r-salbutamol does not increase toughness of meat. 
R-salbutamol needs to be tested on a later maturing breed which normally go into feedlot systems at 
a higher age, to see if the same lack of differences in fat metabolism is observed. Growth and skeletal 
muscle may also show more effects due to increased beta receptors. 
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Chapter 5: 
The effect of r-salbutamol on growth, feed efficiency, carcass characteristics 
and meat quality of Merino feedlot lambs 
5.1 Abstract 
The effect the beta agonist r-salbutamol (S) has on growth, feed efficiency and carcass characteristics 
of late maturing Merino feedlot lambs was evaluated. Fifty six lambs were housed indoors at 
Welgevallen experimental farm, Stellenbosch. Four treatments were fed (14 animals per treatment), 
a control or one of three concentrations of r-salbutamol (S). The control received Meadow complete 
sheep finisher® pellets and the three treatment groups received the same finisher pellets but with 
110mg S/kg, 135mg S/kg and 160 mg S/kg feed, respectively. The animals were blocked and randomly 
assigned to treatments according to starting weight before the onset of the trial. The trial ran for 28 
days of which animals had ad libitum access to feed and quality water. After the trial, lambs were 
slaughtered where individual weights of offal and primal cuts were determined. A sample of the 
longissimus dorsi muscle was taken for physical measurements such as, pH, cooking loss and shear 
force. A 3-rib cut of the right side of each animal was taken to determine longissimus muscle area and 
fat thickness. It was also used to determine the ratio of muscle to fat to bone of each animal. No 
sensory analysis was done as was the case in Chapter 4. No differences in growth or carcass 
characteristics were observed and only a few minor differences were observed between offal and 
primal cuts from different treatments. R-salbutamol had no significant effect on toughness of meat. 
The most pronounced effect r-salbutamol had on Merino lambs was the increase in percentage muscle 
and the lack of difference in percentage fat of the 160mg S/kg group. This suggests that r-salbutamol 
was effective in muscle metabolism but not as effective in fat metabolism. However, results are 
conflicting as subcutaneous fat thickness was reduced for the 160 mg S/kg group compared to the 
control. Lipid metabolism is thus also involved but is not as pronounced as muscle metabolism. 
5.2 Introduction 
Feedlot production systems in South Africa prefer medium maturing dual-purpose breeds such as 
Dormer and Dohne Merino because of their better growth and younger slaughter age (Beukes et al., 
2013). However, the Merino which is late maturing breed, accounts for almost half of the sheep 
population in South Africa as reported by Champher et al., (1998) and cited by Van der Westhuizen 
(2010). The Merino thus plays an important role in meat production of feedlot systems. Being a late 
maturing breed, the Merino has a higher dressing percentage and lower fat content when slaughtered 
at a younger age, making it more acceptable to the modern consumer (Beukes et al., 2013). Merino 
sheep can also enter the feedlot at an older age due to their late maturity. Animals with a higher age 
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tend to show better response to beta-agonists (Fiems, 1987; Liu et al., 1981). In the earlier study with 
r-salbutamol on Dohne Merino lambs (Chapter 4), the lower age of animals (4 months vs 6 months) 
seemed to result in reduced effects of the beta-agonist r-salbutamol. With beta-agonists playing a 
major role in South African feedlot systems due to their ability to improve growth, feed efficiency and 
carcass characteristics, it is important to evaluate the effects of beta-agonists on Merino sheep 
(Vasconcelos et al., 2008; Elam et al., 2009; Montgomery et al., 2009; Lopez-Carlos et al., 2010; Salinas-
Chavira et al., 2006). The aim of this study was thus to test the effect the beta-agonist r-salbutamol 
has on growth, feed efficiency and carcass characteristics of the late maturing Merino breed. 
5.3 Materials and methods 
5.3.1 Animals 
A total of 65 castrated Merino lambs with an average age of eight months were obtained from the 
Swellendam area in the Western Cape. Animals with a weight range of 35-40 kilograms were selected 
from a larger flock and housed in the same pens on Welgevallen experimental farm as in the previous 
trial (Chapter 4). All lambs were shorn to improve feedlot performance. The protocol and methods 
used in Chapter 4 were repeated for this trial, with 56 from the 65 lambs blocked according to weight 
and divided into individual pens prior to commencement of the trial. 
5.3.2 Experimental design and treatments 
Although the trial had the same experimental design as in Chapter 4; it differed in that the wethers 
were randomly divided into individual pens for the first 14 days where after they were blocked to be 
assigned to treatments for the start of the feeding trial (rather than being blocked 14 days before 
the start of the trial). This was done to limit live weight differences between the lambs when the 
animals started receiving the experimental diets. Treatment diets again consisted of Meadow® 
complete sheep finisher pellets with 0, 110, 135, and 160 mg S/kg feed (detail of feed composition, 
etc. in Chapter 4). Treatments were also allocated as in the previous trial.  
All data collection as pertaining to feed intake, performance, carcass measurements, etc. were similar 
to that described in Chapter 4 with carcasses also being classified according to South African legislation 
(Agricultural Product Standards Act, 1990. Act No.119 of 1990). Fifty one of the lambs received an A2 
classification and five reached an A3 classification (Table 5.1). 
 
Table 5.1 Carcass classification according to South African legislation of the carcasses from each 
treatment 
Classification Treatment 
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Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
n=14 n=14 n=14 n=14 
A2 13 13 13 12 
A3 1 1 1 2 
 
Only physical measurements however, were done on the Longissimus Dorsi (LD) muscle and no 
sensory analysis. 
The same statistical analyses were also performed as described previously.  
5.4 Results and discussion 
5.4.1 Feedlot performance: Average daily gain, Dry matter intake and Feed conversion ratio 
In Table 5.2 the growth data is summarised for the 28 day feeding period as in the previous chapter 
(Chapter 4) but for Merino sheep. No significant (P> 0.05) differences were observed for any of the 
growth parameters in Merinos whilst the 160 mg S/kg feed fed to Dohne Merinos had a better FCR 
(Table 4.5). 
Table 5.2 LSMeans ± SD of dry matter intake (DM intake), average daily gain (ADG), average daily gain 
calculated from the slope (ADG from slope), feed conversion ratio (FCR) and feed conversion ratio 
calculated from the slope (FCR from slope) of the four treatment diets containing different 
concentrations of r-salbutamol.  
 Parameter measured 
 
Treatment 
P-value Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=14) 
DM intake (kg/day) 1.62 ± 0.21 1.63 ± 0.20 1.68 ± 0.15 1.62 ± 0.17 0.22 
ADG (kg) 0.21 ± 0.06 0.21 ± 0.06 0.21 ± 0.06 0.22 ± 0.08 0.65 
ADG from slope (kg) 0.21 ± 0.06 0.21 ± 0.06 0.21 ± 0.06 0.22 ± 0.09 0.67 
FCR (kg) 8.31 ± 1.93 8.21 ± 1.93 8.72 ± 2.24 8.48 ± 2.92 0.13 
FCR from slope (kg) 8.33 ± 2.01 8.28 ± 1.89 8.67 ± 2.18 8.50 ± 3.12 0.19 
  
As found in Dohne Merinos (Chapter 4), dry matter intake and average daily gain was unaffected by r-
salbutamol. However, differences were found between Dohne Merinos and Merinos when comparing 
FCR. In this study Merinos showed no significant differences between treatments while Dohne 
Merinos showed a difference in FCR between the control and 160 mg S/kg for FCR over time and for 
FCR calculated from the slope, the control differed from both the 135 mg S/kg and the 160mg S/kg. 
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Previous studies also suggest no effect on intake but improvements in ADG and FCR when cattle and 
sheep are supplemented with beta-agonists (Vasconcelos et al., 2008; Montgomery et al., 2009; Elam 
et al., 2009; Lopez-Carlos et al., 2010; Salinas-Chavira et al., 2006). However, Steenekamp (2014) 
found no differences in FCR with both r-salbutamol and zilpaterol hydrochloride when fed to feedlot 
bulls. 
5.4.2 Feed Conversion Ratio and Average Daily Gain calculations with mg r-salbutamol intake as 
main effect 
Actual intake of the active ingredient r-salbutamol was calculated as in Chapter 4 with the control 
group taken as zero r-salbutamol and for the other 3 groups, the total intake in mg was classified as 
low with a range of 3926.23<x<5688.98mg intake of r-salbutamol, medium with a range of 
5745.85<x<6848.28mg intake of r-salbutamol and high with a range of 6859.88<x<8682.40mg intake 
of r-salbutamol. Data were analysed as in Chapter 4 (Table 4.6). 
Table 5.3 Summary statistics (LSMeans ± SD) of average daily gain (ADG) and feed conversion ratio 
(FCR) calculations with actual r-salbutamol intake as main effect. 
Parameter measured 
  
Treatment 
P-value Zero Low Medium High 
(n=14) (n=14) (n=14) (n=14) 
ADG (kg/day)  0.18 ± 0.22 0.22 ± 0.12 0.21 ± 0.23 0.17 ± 0.19 0.92 
FCR (kg feed/kg weight gain) 7.02 ± 5.91 6.74 ± 4.80 6.28 ± 7.44 5.72 ± 8.13 0.96 
  
No significant differences were found between the four groups of different intake levels of r-
salbutamol. FCR decreased as r-salbutamol increased but it was non-significant. This is mainly due to 
the large variation between lambs within the four groups. In Chapter 4, Dohne Merinos had similar 
results with no differences observed between treatments. However, other authors suggest increased 
ADG and FCR with beta-agonist supplementation in lambs as discussed in Chapter 4 (Lopez-Carlos et 
al., 2010; Salinas-Chavira et al., 2006). 
5.4.3 Carcass and slaughtering data 
The carcass and slaughtering data of the four treatments which except for cold carcass mass, were 
collected on the day of slaughter, is summarised in Table 5.4.  Live weight, warm carcass mass, cold 
carcass mass, dressing out % and pH45 did not differ (P> 0.05) between treatment groups with varying 
concentrations of r-salbutamol. 
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Table 5.4 LSMeans ± SD of live weight at slaughter, warm carcass mass, cold carcass mass, dressing 
out percentage and carcass pH45 (45 minutes post mortem) of the four treatment groups. 
Parameters measured 
  
Treatment 
P-
valu
e 
Control 
110 mg 
S/kg 
135 mg 
S/kg 
160 mg 
S/kg 
(N=14) (N=14) (N=14) (N=14) 
Live weight before slaughter 
(kg) 
44.04 ± 
3.51 
44.07 ± 
3.44 
44.93 ± 
2.50 
43.93 ± 
3.29 
0.56 
Warm Carcass mass (kg) 
23.83 ± 
1.66 
23.76 ± 
1.68 
23.38 ± 
1.60 
23.82 ± 
2.02 
0.83 
Cold Carcass mass (kg) 
23.44 ± 
1.64 
23.43 ± 
1.72 
23.00 ± 
1.56 
23.47 ± 
1.98 
0.77 
Dressing out percentage  54.2 ± 2.74 54.0 ± 2.59 52.1 ± 3.71 54.3 ± 3.02 0.22 
pH45 6.47 ± 0.59 6.59 ± 0.79 6.51 ± 0.78 6.31 ± 0.61 0.75 
  
Results are similar to that in Chapter 4; R-salbutamol had no-effect on carcass parameters in Merinos 
as was also observed in Dohne Merinos (Table 4.7). Normally, beta-agonist supplementation in sheep 
and cattle result in higher dressing out percentages and heavier carcass mass (Moody et al., 2000; 
Lopez-Carlos et al., 2010). However, results in sheep are inconsistent as described in Chapter 4 (Felix 
et al., 2005; Robles-Estrada et al., 2009). R-salbutamol also had no effect on carcass characteristics 
when fed to feedlot bulls (Steenekamp, 2014). However, improved warm carcass mass and dressing 
out percentage was observed with r-salbutamol supplementation in pigs (Marchant-Forde et al., 
2012). 
5.4.4 Data of individual cuts and organs for determination of muscle distribution in the carcass 
The data of individual body parts and organs collected on the day of slaughter are summarised in Table 
5.5. All values are expressed as a percentage of live weight as determined immediately before 
slaughter. In Table 5.6 the individual or primal cuts taken 24 hours after slaughter are summarised.  
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Table 5.5 LSMeans (± SD) of organs and individual body parts expressed as a percentage of live weight 
to wethers fed various concentrations of r-salbutamol.  
Parameters measured 
(%)* 
Treatment 
P-value Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(N=14) (N=14) (N=14) (N=14) 
Head  5.54ᵃᵇ ± 0.38 5.35ᵃᵇ ± 0.46 5.28ᵇ ± 0.35 5.60ᵃ ± 0.43 0.05 
Feet 2.66 ± 0.20 2.64 ± 0.21 2.60 ± 0.20 2.68 ± 0.24 0.74 
Skin 10.10 ± 0.83 9.59 ± 0.71 9.63 ± 0.97 9.93 ± 0.72 0.28 
Pluck 5.01ᵃ ± 0.18 4.70ᵇ ± 0.20 5.02ᵃ ± 0.23 4.86ᵃᵇ ± 0.30 <0.01 
Intestines 19.20 ± 1.31 18.52 ± 1.34 18.37 ± 1.88 18.59 ± 1.76 0.55 
Omental fat 1.58 ± 0.37 1.81 ± 0.40 1.62 ± 0.40 1.56 ± 0.45 0.37 
a,b means in a row with different superscript letters differ (P≤ 0.05).  
* The values are expressed as a percentage of the live weight.  
Again the head and pluck differed between treatments as in Chapter 4 (Table 4.8). However, the 
percentage omental fat showed no significant differences. Dohne Merinos had a significantly larger 
percentage omental fat for the group with the highest concentration of r-salbutamol. This is in 
contrast with other studies suggesting a reduction in carcass fat with beta-agonist administration. In 
other studies it was found that beta-agonists such as zilpaterol hydrochloride has no effect on non-
carcass components in sheep when expressed as a percentage of live weight (Li et al., 2000; Aguilera-
Soto et al., 2008). This is due to beta-agonists having a low hypertrophic effect on visceral organs and 
a higher effect on skeletal muscle (Li et al., 2000). 
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Table 5.6 LSMeans ± SD of individual or primal cuts of Merino wethers fed the different concentrations 
of r-salbutamol.  
Parameters measured 
(%)* 
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(N=14) (N=14) (N=14) (N=14) 
Neck 3.58 ± 0.35 3.64 ± 0.38 3.73 ± 0.43 3.64 ± 0.33 0.77 
Shoulders  16.71 ± 1.03 17.05 ± 1.03 17.15 ± 0.82 17.24 ± 1.14 0.56 
Forelegs 11.68 ± 0.76 12.29 ± 1.21 12.46 ± 1.00 12.11 ± 1.19 0.30 
Ribs 10.55ᵃ ± 0.95 10.04ᵃᵇ ± 0.55 9.92ᵇ ± 0.87 10.03ᵃᵇ ± 0.57 0.03 
Back 18.81 ± 1.19 19.61 ± 0.85 18.82 ± 1.21 19.20 ± 0.88 0.15 
Hind legs 31.71 ± 0.95 31.58 ± 0.98 32.10 ± 0.93 32.12 ± 1.04 0.36 
Shins 2.29 ± 0.17 2.43 ± 0.31 2.51 ± 0.40 2.42 ± 0.35 0.36 
Kidneys 0.56ᵇ ± 0.05 0.58ᵃᵇ ± 0.03 0.61ᵃ ± 0.06 0.56ᵇ ± 0.04 0.04 
Kidney fat 2.74ᵃᵇ ± 0.79 2.92ᵃ ± 0.67 2.50ᵃᵇ ± 0.61 2.28ᵇ ± 0.73 0.05 
a,b means in a row with different superscript letters differ (P≤ 0.05).  
* Values expressed as a percentage of cold carcass weight  
The only parameters showing significant differences are % kidneys, % kidney fat and % ribs. 
Parameters such as % shoulders, % fore legs, % hind legs, % neck, % back and % shins showed no 
significant differences between treatment groups. The percentage kidney fat was significantly higher 
for the group with the lowest concentration of r-salbutamol compared to the highest concentration 
of r-salbutamol. However, the largest concentration does not differ from the control. In Dohne 
Merinos, kidney fat also did not differ between different treatments of r-salbutamol (Table 4.9). This 
further suggests that r-salbutamol may not decrease fat in the carcass as other beta-agonists do. 
Zilpaterol hydrochloride increased hind quarter percentage and decreased forequarter percentage in 
a study on feedlot lambs (Macias-cruz et al., 2010). As on Dohne Merinos in Chapter 4, r-salbutamol 
showed no effect on the hindquarter percentages but also showed no decrease in forequarter 
percentages in Merino lambs. Zilpaterol hydrochloride further had no effect on the loin section when 
fed to feedlot lambs (Macias-cruz et al., 2010). Similar results were found in Dohne Merinos (Table 
4.9) and now also in Merinos. 
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5.4.5 Image analysis of eye muscle area and fat thickness 
Table 5.7 Summary statistics (LSMeans ± SD) for image analysis of eye muscle (m. longissimus muscle) 
area and subcutaneous fat thickness (in cm) of the 3-rib cut. No significant differences were found in 
eye muscle area but fat thickness however, did show significant differences. 
Parameters measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=13) 
Eye muscle area (cm²) 25.10 ± 4.28 23.80 ± 3.98 23.71 ± 2.99 23.36 ± 4.91 0.77 
Fat thickness (cm) 0.84ᵃ ± 0.28 0.75ᵃᵇ ± 0.15 0.74ᵃᵇ ± 0.19 0.66ᵇ ± 0.15 0.03 
a,b means in a row with different superscript letters differ (P≤ 0.05).  
Subcutaneous fat depth became thinner as the amount of r-sulbutamol consumed increased. In Dohne 
Merinos no significant effects was observed with neither eye muscle area nor fat thickness. Authors 
suggest that beta-agonists increases eye muscle area in feedlot lambs which contradicts the current 
results (Lopez-Carlos et al., 2010; Macias-Cruz et al., 2010). However, in Merinos r-salbutamol 
decreases fat thickness. This is in accordance with results from other beta-agonists and also r-
salbutamol in bulls, but contradicts results with r-salbutamol in Dohne Merino lambs (Table 4.10). This 
may be a result the fact the Merino sheep were older and more energy would normally be partitioned 
towards subcutaneous fat deposition.  
5.4.6 Carcass composition (percentage muscle to fat to bone) 
In Table 5.8 the percentage dissected muscle to fat to bone of the 3-rib cut is summarised for 
determination of carcass composition.  
Only the percentage muscle showed differences (P≤ 0.05) between treatments. In Dohne Merinos 
(Table 4.11), percentage muscle and percentage fat were highest for the group with the highest 
concentration of r-salbutamol (160mg S/kg; Table 4.9), percentage bone was lowest. In Merinos the 
percentage muscle was also significantly higher than the control for both the 160mg S/kg and the 
135 mg S/kg. This is in accordance with other studies suggesting an increase in muscularity with 
beta-agonist supplementation (Lopez-Carlos et al., 2010). R-salbutamol when compared to zilpaterol 
hydrochloride in feedlot bulls, had larger percentages muscle than the control as well as zilpaterol 
hydrochloride treated bulls (Steenekamp, 2014). However, no significant differences were observed 
for either the percentage fat or percentage bone as was seen with Dohne Merinos. This again 
contradicts other studies suggesting a reduction in carcass fat, resulting in a leaner carcass 
(Rikhardsson et al., 1991; Salinas-Chavira et al., 2005). 
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Table 5.8 Summary statistics (LSMeans ± SD) of carcass composition (percentage muscle to bone to 
fat) done on the 3-rib cut. 
Parameter Measured 
(%)* 
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=13) 
Percentage muscle  35.91ᵇ ± 3.01 38.16ᵃ ± 3.13 36.93ᵃᵇ ± 2.07 38.31ᵃ ± 3.10 0.05 
Percentage fat  41.02 ± 5.19 39.67 ± 4.69 39.97 ± 2.94 39.37 ± 5.16 0.72 
Percentage bone  23.07 ± 2.74 22.17 ± 3.79 23.10 ± 2.89 22.32 ± 3.19 0.52 
a,b means in a row with different superscript letters differ (P≤ 0.05).  
* calculated as % of 9th-12th 3-rib cut’s weight  
 
5.4.7 Physical measurements 
The pH values of an uncooked sample of the longissimus dorsi muscle, the percentage cooking loss, 
and the average shear force value are summarised in Table 5.9. 
 
Table 5.9 LSMeans ± SD of pH before cooking, percentage cooking loss and average shear force values 
Parameters measured 
  
Treatment 
P-
value 
Control 110 mg S/kg 135 mg S/kg 160 mg S/kg 
(n=14) (n=14) (n=14) (n=14) 
pH Raw 5.61 ± 0.07 5.61 ± 0.04 5.63 ± 0.08 5.63 ± 0.08 0.88 
% Cooking loss 32.05 ± 6.56 30.35 ± 5.37 30.73 ± 8.19 28.92 ± 8.19 0.75 
Instron (N) 23.49 ± 4.93 24.70 ± 5.89 24.57 ± 4.84 23.42 ± 5.03 0.87 
  
No significant differences (P> 0.05) between treatments were observed with the raw pH and the % 
cooking loss of the 56 samples. As also observed in the Dohne Merinos (Table 4.12), average shear 
force values between treatments did not differ significantly in Merinos. This further suggests that r-
salbutamol does not have a significant effect on shear force values of meat indicating no increase in 
toughness as has been reported for other beta-agonists (Montgomery et al., 2009; Elam et al., 2009). 
Zilpaterol hydrochloride being a beta₂-agonist has a more pronounced effect on muscle metabolism 
and results in bigger muscle fibres which makes it tougher (Dunshea et al., 2005; Leheska et al., 2009; 
Strydom et al., 2009). R-salbutamol seems to have a less aggressive effect on muscle metabolism than 
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zilpaterol hydrochloride as R-salbutamol treated bulls also showed no effect on shear force of meat 
compared to control bulls and had significantly lower shear force values compared to zilpaterol 
treated bulls (Steenekamp, 2014). 
5.5 Conclusion 
In this study with Merinos, no significant differences were found in growth, feed efficiency and carcass 
characteristics with r-salbutamol supplementation. With offal and primal cut weights, minimal 
differences were found. The concentration of r-salbutamol that seemed to perform best is the 160 mg 
S/kg group as seen with Dohne Merinos in Chapter 4. This group exhibited a higher percentage of 
carcass muscle in this study, suggesting that r-salbutamol may be effective in skeletal muscle 
metabolism (P-value of 0.05). Although fat seemed unaffected in the kidneys and abdominal area, 
subcutaneous fat thickness was reduced in the 160 mg S/kg group. Different r-salbutamol 
concentrations had no effect on shear force of meat. Meat tenderness is thus unaffected by r-
salbutamol supplementation.  
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Chapter 6 
General conclusion 
It was hypothesized that r-salbutamol would improve digestibility, increase growth and feed efficiency 
and also improve carcass characteristics of feedlot lambs without the added disadvantages of 
increasing toughness of meat as alternative beta-agonists tend to do. The improved carcass 
characteristics include better dressing out percentages, increased percentage of carcass muscle and a 
decreased fat percentage or carcass fat. The potential increase in digestion was expected due to r-
salbutamol influencing the beta-receptors on smooth muscle and also the effect it has on rumen 
microorganisms. 
In the digestibility trial (Chapter 3) r-salbutamol had no effect on the apparent digestibility of Dohne 
Merino feedlot lambs. All digestibility coefficients (OMD, NDF, CP, ash and N-retention) were 
unaffected when supplemented with 135 mg r-salbutamol per kg of feed. Higher doses of r-salbutamol 
may have an effect on apparent digestibility of feedlot lambs and a concentration of at least 160 mg 
S/kg is suggested for further research before any recommendations are made. 
In Dohne Merinos (Chapter 4), feed efficiency was improved in the group with the highest 
concentration of 160 mg r-salbutamol per kg of feed but no effects were observed on ADG between 
treatments. Carcass characteristics such as warm carcass mass, cold carcass mass and dressing out 
percentage did not differ between treatments. Minimal effects were observed with offal and primal 
cut yields, with fat in the abdominal area and around the kidneys unaffected by r-salbutamol in the 
highest concentration. Percentage muscle was increased while percentage bone was decreased and 
percentage fat unaffected in carcasses treated with the highest concentration of r-salbutamol. 
Subcutaneous fat thickness was also unaffected in all concentrations of r-salbutamol fed. This suggests 
that r-salbutamol was effective in muscle anabolism but less effective in lipid metabolism. This may 
be due to younger animals having lower receptor numbers. R-salbutamol also had no effect on 
perceived toughness as evaluated by the descriptive sensory analysis or on toughness tested 
mechanically by an Instron machine.  
In the later maturing Merinos (Chapter 5), no differences were observed in growth (ADG), feed 
efficiency (FCR) and carcass characteristics such as warm carcass mass, cold carcass mass and dressing 
out percentage between various concentrations of r-salbutamol. The change of pharmocodynamical 
properties in older animals are suggested to be the reason animals did not perform as expected. 
Minimal effects were found in offal and primal cuts between treatments. Again the optimal 
concentration seemed to be the 160 mg S/kg group as seen in Dohne Merinos (Chapter 4) where a 
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higher percentage of carcass muscle was exhibited. Percentage fat, abdominal fat and kidney fat was 
once more unaffected by r-salbutamol supplementation. However, fat thickness was reduced in the 
group with the highest concentration of r-salbutamol. Again, R-salbutamol did not affect the 
tenderness (measured via shear force) of the meat, as r-sulbutamol did not increase the toughness of 
the meat in either the late maturing Merinos or medium maturing Dohne Merinos, it can be concluded 
that r-salbutamol does not increase the toughness of lamb meat. As for digestibility, further research 
needs to be done before recommendations can be made. 
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